diff --git "a/input/TCGA/TCGA_Adrenocortical_Cancer_(ACC)/TCGA.ACC.sampleMap_ACC_clinicalMatrix" "b/input/TCGA/TCGA_Adrenocortical_Cancer_(ACC)/TCGA.ACC.sampleMap_ACC_clinicalMatrix" new file mode 100644--- /dev/null +++ "b/input/TCGA/TCGA_Adrenocortical_Cancer_(ACC)/TCGA.ACC.sampleMap_ACC_clinicalMatrix" @@ -0,0 +1,93 @@ +sampleID _INTEGRATION _PATIENT _cohort _primary_disease _primary_site additional_pharmaceutical_therapy additional_radiation_therapy age_at_initial_pathologic_diagnosis atypical_mitotic_figures bcr_followup_barcode bcr_patient_barcode bcr_sample_barcode clinical_M ct_scan_findings cytoplasm_presence_less_than_equal_25_percent days_to_birth days_to_collection days_to_death days_to_initial_pathologic_diagnosis days_to_last_followup days_to_new_tumor_event_additional_surgery_procedure days_to_new_tumor_event_after_initial_treatment diffuse_architecture distant_metastasis_anatomic_site excess_adrenal_hormone_diagnosis_method_type excess_adrenal_hormone_history_type form_completion_date gender germline_testing_performed histologic_disease_progression_present_indicator histological_type history_of_neoadjuvant_treatment icd_10 icd_o_3_histology icd_o_3_site informed_consent_verified initial_weight invasion_of_tumor_capsule is_ffpe laterality lost_follow_up lymph_node_examined_count metastatic_neoplasm_confirmed_diagnosis_method_name metastatic_neoplasm_confirmed_diagnosis_method_text mitoses_count mitotane_therapy mitotane_therapy_adjuvant_setting mitotane_therapy_for_macroscopic_residual_disease mitotic_rate necrosis new_neoplasm_confirmed_diagnosis_method_name new_neoplasm_event_occurrence_anatomic_site new_neoplasm_event_type new_neoplasm_occurrence_anatomic_site_text new_tumor_event_additional_surgery_procedure new_tumor_event_after_initial_treatment nuclear_grade_III_IV number_of_lymphnodes_positive_by_he oct_embedded other_dx pathologic_N pathologic_T pathologic_stage pathology_report_file_name patient_id person_neoplasm_cancer_status post_surgical_procedure_assessment_thyroid_gland_carcinoma_stats postoperative_rx_tx primary_lymph_node_presentation_assessment primary_therapy_outcome_success radiation_therapy residual_tumor ret sample_type sample_type_id sinusoid_invasion therapeutic_mitotane_levels_achieved therapeutic_mitotane_lvl_macroscopic_residual therapeutic_mitotane_lvl_progression therapeutic_mitotane_lvl_recurrence tissue_prospective_collection_indicator tissue_retrospective_collection_indicator tissue_source_site tumor_tissue_site vial_number vital_status weiss_score weiss_venous_invasion year_of_initial_pathologic_diagnosis _GENOMIC_ID_TCGA_ACC_mutation_curated_bcm_gene _GENOMIC_ID_TCGA_ACC_exp_HiSeqV2_percentile _GENOMIC_ID_data/public/TCGA/ACC/miRNA_HiSeq_gene _GENOMIC_ID_TCGA_ACC_miRNA_HiSeq _GENOMIC_ID_TCGA_ACC_RPPA _GENOMIC_ID_TCGA_ACC_hMethyl450 _GENOMIC_ID_TCGA_ACC_exp_HiSeqV2_exon _GENOMIC_ID_TCGA_ACC_exp_HiSeqV2 _GENOMIC_ID_TCGA_ACC_gistic2thd _GENOMIC_ID_TCGA_ACC_PDMRNAseq _GENOMIC_ID_TCGA_ACC_PDMRNAseqCNV _GENOMIC_ID_TCGA_ACC_exp_HiSeqV2_PANCAN _GENOMIC_ID_TCGA_ACC_gistic2 _GENOMIC_ID_TCGA_ACC_mutation_bcm_gene _GENOMIC_ID_TCGA_ACC_mutation_curated_broad_gene +TCGA-OR-A5J1-01 TCGA-OR-A5J1-01 TCGA-OR-A5J1 TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland NO NO 58 Atypical Mitotic Figures Absent TCGA-OR-A5J1-F60566 TCGA-OR-A5J1 TCGA-OR-A5J1-01A M0 Cytoplasm presence <= 25% Present -21496 4691 1355 0 754 Diffuse Architecture Present Mineralocorticoids 2014-6-11 MALE NO YES Adrenocortical carcinoma- Usual Type No C74.0 8370/1 C74.0 YES 40 Invasion of Tumor Capsule Absent NO Left NO 5 NO NO Mitotic Rate > 5/50 HPF Absent Necrosis Present Imaging Peritoneal Surfaces Distant Metastasis NO YES Nuclear Grade III or IV Absent true No N0 T2 Stage II TCGA-OR-A5J1.8866FD87-4F6F-4D7E-B99A-7DD427ED3BB3.pdf A5J1 WITH TUMOR Persistent distant metastases NO Complete Remission/Response NO R0 Primary Tumor 01 Sinusoid Invasion Absent NO YES OR Adrenal A DECEASED 3 Venous Invasion Absent 2000 TCGA-OR-A5J1-01A-11D-A29I-10 37e88158-0743-45b8-87cf-1d7fe878527f TCGA-OR-A5J1-01 TCGA-OR-A5J1-01 TCGA-OR-A5J1-01A-11D-A29J-05 37e88158-0743-45b8-87cf-1d7fe878527f 37e88158-0743-45b8-87cf-1d7fe878527f TCGA-OR-A5J1-01A-11D-A29H-01 TCGA-OR-A5J1-01 TCGA-OR-A5J1-01 37e88158-0743-45b8-87cf-1d7fe878527f TCGA-OR-A5J1-01A-11D-A29H-01 TCGA-OR-A5J1-01A-11D-A29I-10 TCGA-OR-A5J1-01A-11D-A29I-10 +TCGA-OR-A5J2-01 TCGA-OR-A5J2-01 TCGA-OR-A5J2 TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 44 Atypical Mitotic Figures Present TCGA-OR-A5J2 TCGA-OR-A5J2-01A M1 Lung Involvement Cytoplasm presence <= 25% Present -16090 3124 1677 0 Diffuse Architecture Present Both Clinical and Biochemical Assessments Androgen 2013-12-3 FEMALE NO Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 350 Invasion of Tumor Capsule Present NO Left 1 Imaging Suspected 0 YES YES Mitotic Rate > 5/50 HPF Absent Necrosis Present YES Nuclear Grade III or IV Present 0 true No N0 T3 Stage IV TCGA-OR-A5J2.345C34EE-F031-41A4-B955-BA054F2A3CE1.pdf A5J2 WITH TUMOR Persistent distant metastases YES YES Progressive Disease NO R2 Primary Tumor 01 Sinusoid Invasion Present NO YES OR Adrenal A DECEASED 8 Venous Invasion Present 2004 TCGA-OR-A5J2-01A-11D-A29I-10 421bbd6b-fb2a-4a6d-a298-057c1b65f041 TCGA-OR-A5J2-01 TCGA-OR-A5J2-01 F9762BBB-BCA0-4B54-A2C8-6F81A91DE22F TCGA-OR-A5J2-01A-11D-A29J-05 421bbd6b-fb2a-4a6d-a298-057c1b65f041 421bbd6b-fb2a-4a6d-a298-057c1b65f041 TCGA-OR-A5J2-01A-11D-A29H-01 TCGA-OR-A5J2-01 TCGA-OR-A5J2-01 421bbd6b-fb2a-4a6d-a298-057c1b65f041 TCGA-OR-A5J2-01A-11D-A29H-01 TCGA-OR-A5J2-01A-11D-A29I-10 TCGA-OR-A5J2-01A-11D-A29I-10 +TCGA-OR-A5J3-01 TCGA-OR-A5J3-01 TCGA-OR-A5J3 TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland YES NO 23 Atypical Mitotic Figures Absent TCGA-OR-A5J3-F59590 TCGA-OR-A5J3 TCGA-OR-A5J3-01A M0 Vena Cava Involvement/thrombus Cytoplasm presence <= 25% Present -8624 1584 0 2091 1583 1149 Diffuse Architecture Present Both Clinical and Biochemical Assessments Androgen|Cortisol 2014-5-15 FEMALE YES Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 310 Invasion of Tumor Capsule Absent NO Left NO 4 6 YES YES Mitotic Rate > 5/50 HPF Present Necrosis Present Imaging Lung Distant Metastasis YES YES Nuclear Grade III or IV Present 0 true No N0 T3 Stage III TCGA-OR-A5J3.83F53610-4F40-425B-9B69-BBB94234224F.pdf A5J3 WITH TUMOR No imaging evidence of disease NO YES Complete Remission/Response NO R0 Primary Tumor 01 Sinusoid Invasion Absent YES YES NO YES OR Adrenal A LIVING 6 Venous Invasion Present 2008 TCGA-OR-A5J3-01A-11D-A29I-10 83b02107-0c7c-450d-84aa-9ed4e1d755c5 TCGA-OR-A5J3-01 TCGA-OR-A5J3-01 21AB5BC5-D822-4C70-BAD0-1E390A55456E TCGA-OR-A5J3-01A-11D-A29J-05 83b02107-0c7c-450d-84aa-9ed4e1d755c5 83b02107-0c7c-450d-84aa-9ed4e1d755c5 TCGA-OR-A5J3-01A-11D-A29H-01 TCGA-OR-A5J3-01 TCGA-OR-A5J3-01 83b02107-0c7c-450d-84aa-9ed4e1d755c5 TCGA-OR-A5J3-01A-11D-A29H-01 TCGA-OR-A5J3-01A-11D-A29I-10 TCGA-OR-A5J3-01A-11D-A29I-10 +TCGA-OR-A5J4-01 TCGA-OR-A5J4-01 TCGA-OR-A5J4 TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 23 Atypical Mitotic Figures Absent TCGA-OR-A5J4 M1 Lung Involvement Cytoplasm presence <= 25% Absent -8451 423 0 Diffuse Architecture Present Both Clinical and Biochemical Assessments Androgen|Cortisol 2013-12-2 FEMALE NO Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES Invasion of Tumor Capsule Present Right 2 Imaging Suspected 77 YES YES Mitotic Rate > 5/50 HPF Present Necrosis Present YES Nuclear Grade III or IV Present 2 No N1 T3 Stage IV A5J4 WITH TUMOR Persistent distant metastases YES YES Progressive Disease NO R2 Primary Tumor 01 Sinusoid Invasion Absent NO YES OR Adrenal DECEASED 6 Venous Invasion Present 2000 TCGA-OR-A5J4-01A-11D-A29I-10 TCGA-OR-A5J4-01 TCGA-OR-A5J4-01 TCGA-OR-A5J4-01A-11D-A29J-05 TCGA-OR-A5J4-01A-11D-A29H-01 TCGA-OR-A5J4-01A-11D-A29H-01 TCGA-OR-A5J4-01A-11D-A29I-10 TCGA-OR-A5J4-01A-11D-A29I-10 +TCGA-OR-A5J5-01 TCGA-OR-A5J5-01 TCGA-OR-A5J5 TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 30 Atypical Mitotic Figures Present TCGA-OR-A5J5 M0 Retroperitoneal Lymph Node Involvement Cytoplasm presence <= 25% Absent -11171 365 0 Diffuse Architecture Absent None 2013-12-3 MALE NO Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES Invasion of Tumor Capsule Present Right 3 YES YES Mitotic Rate > 5/50 HPF Absent Necrosis Present YES Nuclear Grade III or IV Present No N0 T4 Stage III A5J5 WITH TUMOR Persistent locoregional disease YES NO Progressive Disease NO R2 Primary Tumor 01 Sinusoid Invasion Present NO YES OR Adrenal DECEASED 6 Venous Invasion Present 2000 TCGA-OR-A5J5-01A-11D-A29I-10 f72bfbe6-411d-412e-aaab-1a2414e544ec TCGA-OR-A5J5-01 TCGA-OR-A5J5-01 TCGA-OR-A5J5-01A-11D-A29J-05 f72bfbe6-411d-412e-aaab-1a2414e544ec f72bfbe6-411d-412e-aaab-1a2414e544ec TCGA-OR-A5J5-01A-11D-A29H-01 TCGA-OR-A5J5-01 TCGA-OR-A5J5-01 f72bfbe6-411d-412e-aaab-1a2414e544ec TCGA-OR-A5J5-01A-11D-A29H-01 TCGA-OR-A5J5-01A-11D-A29I-10 TCGA-OR-A5J5-01A-11D-A29I-10 +TCGA-OR-A5J6-01 TCGA-OR-A5J6-01 TCGA-OR-A5J6 TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 29 Atypical Mitotic Figures Absent TCGA-OR-A5J6-F59329 TCGA-OR-A5J6 TCGA-OR-A5J6-01A M0 Normal Cytoplasm presence <= 25% Present -10839 2220 0 2703 Diffuse Architecture Present Both Clinical and Biochemical Assessments Androgen|Cortisol 2014-5-8 FEMALE YES Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 340 Invasion of Tumor Capsule Absent NO Right NO NO NO Mitotic Rate > 5/50 HPF Present Necrosis Absent NO Nuclear Grade III or IV Absent true No N0 T2 Stage II TCGA-OR-A5J6.F664D25E-9050-460D-AEAE-AA4BFA515453.pdf A5J6 TUMOR FREE No imaging evidence of disease NO NO Complete Remission/Response NO R0 Primary Tumor 01 Sinusoid Invasion Absent NO YES OR Adrenal A LIVING 3 Venous Invasion Absent 2006 TCGA-OR-A5J6-01A-31D-A29I-10 bb6e0e73-ff48-4627-bce6-f672c06b7de4 TCGA-OR-A5J6-01 TCGA-OR-A5J6-01 BBE6AF7B-BCDD-4179-94E2-2978AF7A03A4 TCGA-OR-A5J6-01A-31D-A29J-05 bb6e0e73-ff48-4627-bce6-f672c06b7de4 bb6e0e73-ff48-4627-bce6-f672c06b7de4 TCGA-OR-A5J6-01A-31D-A29H-01 TCGA-OR-A5J6-01 TCGA-OR-A5J6-01 bb6e0e73-ff48-4627-bce6-f672c06b7de4 TCGA-OR-A5J6-01A-31D-A29H-01 TCGA-OR-A5J6-01A-31D-A29I-10 TCGA-OR-A5J6-01A-31D-A29I-10 +TCGA-OR-A5J7-01 TCGA-OR-A5J7-01 TCGA-OR-A5J7 TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 30 Atypical Mitotic Figures Present TCGA-OR-A5J7 TCGA-OR-A5J7-01A M0 Normal Cytoplasm presence <= 25% Present -11279 1388 490 0 Diffuse Architecture Absent Both Clinical and Biochemical Assessments Androgen|Cortisol 2013-12-2 FEMALE YES Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 120 Invasion of Tumor Capsule Present NO Right 1 3 YES YES Mitotic Rate > 5/50 HPF Absent Necrosis Present YES Nuclear Grade III or IV Present 0 true No N0 T3 Stage III TCGA-OR-A5J7.F9C1971C-5BE2-4722-9A6C-CF4A4AD04352.pdf A5J7 WITH TUMOR No imaging evidence of disease YES YES Progressive Disease NO R1 Primary Tumor 01 Sinusoid Invasion Absent NO NO YES OR Adrenal A DECEASED 6 Venous Invasion Present 2009 TCGA-OR-A5J7-01A-11D-A29I-10 59eb3b91-d706-45de-9bbe-92b32629c58c TCGA-OR-A5J7-01 TCGA-OR-A5J7-01 C89548B7-83CE-40C3-A25C-DE98CEE4415D TCGA-OR-A5J7-01A-11D-A29J-05 59eb3b91-d706-45de-9bbe-92b32629c58c 59eb3b91-d706-45de-9bbe-92b32629c58c TCGA-OR-A5J7-01A-11D-A29H-01 TCGA-OR-A5J7-01 TCGA-OR-A5J7-01 59eb3b91-d706-45de-9bbe-92b32629c58c TCGA-OR-A5J7-01A-11D-A29H-01 TCGA-OR-A5J7-01A-11D-A29I-10 TCGA-OR-A5J7-01A-11D-A29I-10 +TCGA-OR-A5J8-01 TCGA-OR-A5J8-01 TCGA-OR-A5J8 TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 66 Atypical Mitotic Figures Present TCGA-OR-A5J8 TCGA-OR-A5J8-01A M0 Normal Cytoplasm presence <= 25% Present -24266 396 579 0 Diffuse Architecture Present Biochemical Assessment Cortisol 2013-12-3 MALE YES Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 160 Invasion of Tumor Capsule Present NO Left 1 15 YES YES Mitotic Rate > 5/50 HPF Present Necrosis Present YES Nuclear Grade III or IV Present 0 true No N0 T3 Stage III TCGA-OR-A5J8.EA68CD7A-9308-40CD-BB52-CEB36334A146.pdf A5J8 WITH TUMOR No imaging evidence of disease YES YES Complete Remission/Response YES R0 Primary Tumor 01 Sinusoid Invasion Absent NO NO NO YES OR Adrenal A DECEASED 8 Venous Invasion Present 2011 TCGA-OR-A5J8-01A-11D-A29I-10 73fee5d0-d326-484c-95c6-c40c987c6917 TCGA-OR-A5J8-01 TCGA-OR-A5J8-01 8D7AD90D-2927-4106-8DB3-C1F9BA8A6A15 TCGA-OR-A5J8-01A-11D-A29J-05 73fee5d0-d326-484c-95c6-c40c987c6917 73fee5d0-d326-484c-95c6-c40c987c6917 TCGA-OR-A5J8-01A-11D-A29H-01 TCGA-OR-A5J8-01 TCGA-OR-A5J8-01 73fee5d0-d326-484c-95c6-c40c987c6917 TCGA-OR-A5J8-01A-11D-A29H-01 TCGA-OR-A5J8-01A-11D-A29I-10 TCGA-OR-A5J8-01A-11D-A29I-10 +TCGA-OR-A5J9-01 TCGA-OR-A5J9-01 TCGA-OR-A5J9 TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland NO NO 22 Atypical Mitotic Figures Absent TCGA-OR-A5J9-F59596 TCGA-OR-A5J9 TCGA-OR-A5J9-01A M0 Normal Cytoplasm presence <= 25% Present -8175 849 0 1352 414 Diffuse Architecture Present None 2014-5-15 FEMALE NO Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 190 Invasion of Tumor Capsule Absent NO Right NO 6 YES YES Mitotic Rate > 5/50 HPF Present Necrosis Present Imaging Lung Distant Metastasis NO YES Nuclear Grade III or IV Present true No N0 T2 Stage II TCGA-OR-A5J9.4C775CF4-39D7-4246-87A4-4659783A1C18.pdf A5J9 WITH TUMOR No imaging evidence of disease YES NO Complete Remission/Response NO R0 Primary Tumor 01 Sinusoid Invasion Present NO YES OR Adrenal A LIVING 6 Venous Invasion Absent 2010 TCGA-OR-A5J9-01A-11D-A29I-10 a818d2cc-4d45-40df-bfcb-9fa08ebf8490 TCGA-OR-A5J9-01 TCGA-OR-A5J9-01 E058CA44-9D1C-40F2-98D1-BC8A31CC4713 TCGA-OR-A5J9-01A-11D-A29J-05 a818d2cc-4d45-40df-bfcb-9fa08ebf8490 a818d2cc-4d45-40df-bfcb-9fa08ebf8490 TCGA-OR-A5J9-01A-11D-A29H-01 TCGA-OR-A5J9-01 TCGA-OR-A5J9-01 a818d2cc-4d45-40df-bfcb-9fa08ebf8490 TCGA-OR-A5J9-01A-11D-A29H-01 TCGA-OR-A5J9-01A-11D-A29I-10 TCGA-OR-A5J9-01A-11D-A29I-10 +TCGA-OR-A5JA-01 TCGA-OR-A5JA-01 TCGA-OR-A5JA TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 53 Atypical Mitotic Figures Present TCGA-OR-A5JA TCGA-OR-A5JA-01A M1 Lung Involvement Cytoplasm presence <= 25% Present -19436 2931 922 0 Diffuse Architecture Present Retroperitoneum Both Clinical and Biochemical Assessments Androgen 2013-9-17 FEMALE NO Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 180 Invasion of Tumor Capsule Present NO Right Imaging Suspected 90 NO Mitotic Rate > 5/50 HPF Present Necrosis Present NO Nuclear Grade III or IV Present true No N0 T4 Stage IV TCGA-OR-A5JA.6A505565-429B-4D8A-A591-AAB54CF43B66.pdf A5JA WITH TUMOR Persistent distant metastases YES NO NO R1 Primary Tumor 01 Sinusoid Invasion Present NO YES OR Adrenal A DECEASED 9 Venous Invasion Present 2004 TCGA-OR-A5JA-01A-11D-A29I-10 d979c964-68e1-4ea4-a473-69b69cba8e5c TCGA-OR-A5JA-01 TCGA-OR-A5JA-01 969F9640-F208-4C28-91AE-AD429932EC1F TCGA-OR-A5JA-01A-11D-A29J-05 d979c964-68e1-4ea4-a473-69b69cba8e5c d979c964-68e1-4ea4-a473-69b69cba8e5c TCGA-OR-A5JA-01A-11D-A29H-01 TCGA-OR-A5JA-01 TCGA-OR-A5JA-01 d979c964-68e1-4ea4-a473-69b69cba8e5c TCGA-OR-A5JA-01A-11D-A29H-01 TCGA-OR-A5JA-01A-11D-A29I-10 TCGA-OR-A5JA-01A-11D-A29I-10 +TCGA-OR-A5JB-01 TCGA-OR-A5JB-01 TCGA-OR-A5JB TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 52 Atypical Mitotic Figures Present TCGA-OR-A5JB TCGA-OR-A5JB-01A M1 Cytoplasm presence <= 25% Present -19172 4678 551 0 Diffuse Architecture Present brain None 2013-9-17 MALE NO Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 20 Invasion of Tumor Capsule Present NO Right Other, specify excision of brain met 15 Mitotic Rate > 5/50 HPF Present Necrosis Present Nuclear Grade III or IV Present true No N0 T4 Stage IV TCGA-OR-A5JB.81022A25-6D64-419D-9B97-22348E17ECEA.pdf A5JB Persistent distant metastases R1 Primary Tumor 01 Sinusoid Invasion Absent NO YES OR Adrenal A DECEASED 7 Venous Invasion Absent 2000 TCGA-OR-A5JB-01A-11D-A29I-10 26861b93-29de-42df-80d6-23260d450391 TCGA-OR-A5JB-01 TCGA-OR-A5JB-01 TCGA-OR-A5JB-01A-11D-A29J-05 26861b93-29de-42df-80d6-23260d450391 26861b93-29de-42df-80d6-23260d450391 TCGA-OR-A5JB-01A-11D-A29H-01 TCGA-OR-A5JB-01 TCGA-OR-A5JB-01 26861b93-29de-42df-80d6-23260d450391 TCGA-OR-A5JB-01A-11D-A29H-01 TCGA-OR-A5JB-01A-11D-A29I-10 TCGA-OR-A5JB-01A-11D-A29I-10 +TCGA-OR-A5JC-01 TCGA-OR-A5JC-01 TCGA-OR-A5JC TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 37 Atypical Mitotic Figures Present TCGA-OR-A5JC Cytoplasm presence <= 25% Present -13862 1750 0 Diffuse Architecture Present Biochemical Assessment Estrogen 2013-9-17 MALE NO Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES Invasion of Tumor Capsule Absent Left 24 Mitotic Rate > 5/50 HPF Present Necrosis Present Nuclear Grade III or IV Present No A5JC NO Primary Tumor 01 Sinusoid Invasion Present NO YES OR Adrenal DECEASED 8 Venous Invasion Present 2001 TCGA-OR-A5JC-01A-11D-A29I-10 c51255ac-840d-44c2-87ae-ed91cc635e85 TCGA-OR-A5JC-01 TCGA-OR-A5JC-01 TCGA-OR-A5JC-01A-11D-A29J-05 c51255ac-840d-44c2-87ae-ed91cc635e85 c51255ac-840d-44c2-87ae-ed91cc635e85 TCGA-OR-A5JC-01A-11D-A29H-01 TCGA-OR-A5JC-01 TCGA-OR-A5JC-01 c51255ac-840d-44c2-87ae-ed91cc635e85 TCGA-OR-A5JC-01A-11D-A29H-01 TCGA-OR-A5JC-01A-11D-A29I-10 TCGA-OR-A5JC-01A-11D-A29I-10 +TCGA-OR-A5JD-01 TCGA-OR-A5JD-01 TCGA-OR-A5JD TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 57 Atypical Mitotic Figures Absent TCGA-OR-A5JD-F71752 TCGA-OR-A5JD TCGA-OR-A5JD-01A M0 Cytoplasm presence <= 25% Present -20989 2571 0 3038 Diffuse Architecture Present None 2015-3-30 FEMALE NO Adrenocortical Carcinoma- Oncocytic Type No C74.0 8370/3 C74.0 YES 40 Invasion of Tumor Capsule Absent NO Left NO 4 NO Mitotic Rate > 5/50 HPF Absent Necrosis Absent NO Nuclear Grade III or IV Present true No N0 T2 Stage II TCGA-OR-A5JD.AA05D1FB-38B5-4D96-B9EE-07523C95C481.pdf A5JD TUMOR FREE No imaging evidence of disease NO Complete Remission/Response NO R0 Primary Tumor 01 Sinusoid Invasion Absent NO YES OR Adrenal A LIVING 3 Venous Invasion Absent 2005 TCGA-OR-A5JD-01A-11D-A29I-10 8067d29d-a249-42b9-bd9e-de47513a4230 TCGA-OR-A5JD-01 TCGA-OR-A5JD-01 TCGA-OR-A5JD-01A-11D-A29J-05 8067d29d-a249-42b9-bd9e-de47513a4230 8067d29d-a249-42b9-bd9e-de47513a4230 TCGA-OR-A5JD-01A-11D-A29H-01 TCGA-OR-A5JD-01 TCGA-OR-A5JD-01 8067d29d-a249-42b9-bd9e-de47513a4230 TCGA-OR-A5JD-01A-11D-A29H-01 TCGA-OR-A5JD-01A-11D-A29I-10 TCGA-OR-A5JD-01A-11D-A29I-10 +TCGA-OR-A5JE-01 TCGA-OR-A5JE-01 TCGA-OR-A5JE TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 17 Atypical Mitotic Figures Present TCGA-OR-A5JE TCGA-OR-A5JE-01A M0 Cytoplasm presence <= 25% Present -6455 2703 2105 0 Diffuse Architecture Present Biochemical Assessment Cortisol 2013-9-17 FEMALE NO Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 50 Invasion of Tumor Capsule Present NO Left 60 YES YES Mitotic Rate > 5/50 HPF Present Necrosis Present YES Nuclear Grade III or IV Present true No N0 T1 Stage I TCGA-OR-A5JE.80EDB29A-262A-486D-B31A-EA015FA8A362.pdf A5JE WITH TUMOR YES NO R0 Primary Tumor 01 Sinusoid Invasion Present NO YES OR Adrenal A DECEASED 8 Venous Invasion Absent 2005 TCGA-OR-A5JE-01A-11D-A29I-10 223e2af0-95a2-49f2-84a2-13379cf72ea9 TCGA-OR-A5JE-01 TCGA-OR-A5JE-01 TCGA-OR-A5JE-01A-11D-A29J-05 223e2af0-95a2-49f2-84a2-13379cf72ea9 223e2af0-95a2-49f2-84a2-13379cf72ea9 TCGA-OR-A5JE-01A-11D-A29H-01 TCGA-OR-A5JE-01 TCGA-OR-A5JE-01 223e2af0-95a2-49f2-84a2-13379cf72ea9 TCGA-OR-A5JE-01A-11D-A29H-01 TCGA-OR-A5JE-01A-11D-A29I-10 TCGA-OR-A5JE-01A-11D-A29I-10 +TCGA-OR-A5JF-01 TCGA-OR-A5JF-01 TCGA-OR-A5JF TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 69 Atypical Mitotic Figures Present TCGA-OR-A5JF-F60581 TCGA-OR-A5JF M0 Cytoplasm presence <= 25% Present -25502 0 2015 Diffuse Architecture Absent Biochemical Assessment Cortisol 2014-6-11 FEMALE NO Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES Invasion of Tumor Capsule Present Left NO 4 YES YES Mitotic Rate > 5/50 HPF Absent Necrosis Absent NO Nuclear Grade III or IV Present No N0 T2 Stage II A5JF TUMOR FREE No imaging evidence of disease YES Complete Remission/Response YES R0 Primary Tumor 01 Sinusoid Invasion Absent YES NO YES OR Adrenal LIVING 4 Venous Invasion Absent 2007 TCGA-OR-A5JF-01A-11D-A29I-10 ba350477-3c49-4258-8409-f39447687497 TCGA-OR-A5JF-01 TCGA-OR-A5JF-01 TCGA-OR-A5JF-01A-11D-A29J-05 ba350477-3c49-4258-8409-f39447687497 ba350477-3c49-4258-8409-f39447687497 TCGA-OR-A5JF-01A-11D-A29H-01 TCGA-OR-A5JF-01 TCGA-OR-A5JF-01 ba350477-3c49-4258-8409-f39447687497 TCGA-OR-A5JF-01A-11D-A29H-01 TCGA-OR-A5JF-01A-11D-A29I-10 TCGA-OR-A5JF-01A-11D-A29I-10 +TCGA-OR-A5JG-01 TCGA-OR-A5JG-01 TCGA-OR-A5JG TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 61 Atypical Mitotic Figures Present TCGA-OR-A5JG TCGA-OR-A5JG-01A M1 Retroperitoneal Lymph Node Involvement Cytoplasm presence <= 25% Present -22390 1771 541 0 Diffuse Architecture Present left cervical lymph node Both Clinical and Biochemical Assessments Cortisol 2013-10-3 MALE NO Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 60 Invasion of Tumor Capsule Present NO Left 8 100 YES Mitotic Rate > 5/50 HPF Present Necrosis Present Nuclear Grade III or IV Present 6 true No N1 T4 Stage IV TCGA-OR-A5JG.15F6D8D6-878A-410F-8289-D3CEAB7E5D21.pdf A5JG WITH TUMOR Persistent distant metastases YES YES R1 Primary Tumor 01 Sinusoid Invasion Present NO YES OR Adrenal A DECEASED 9 Venous Invasion Present 2008 TCGA-OR-A5JG-01A-11D-A29I-10 60c8c1da-fea6-41f7-ba5b-33afba1ef301 TCGA-OR-A5JG-01 TCGA-OR-A5JG-01 TCGA-OR-A5JG-01A-11D-A29J-05 60c8c1da-fea6-41f7-ba5b-33afba1ef301 60c8c1da-fea6-41f7-ba5b-33afba1ef301 TCGA-OR-A5JG-01A-11D-A29H-01 TCGA-OR-A5JG-01 TCGA-OR-A5JG-01 60c8c1da-fea6-41f7-ba5b-33afba1ef301 TCGA-OR-A5JG-01A-11D-A29H-01 TCGA-OR-A5JG-01A-11D-A29I-10 TCGA-OR-A5JG-01A-11D-A29I-10 +TCGA-OR-A5JH-01 TCGA-OR-A5JH-01 TCGA-OR-A5JH TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 32 Atypical Mitotic Figures Absent TCGA-OR-A5JH-F60573 TCGA-OR-A5JH TCGA-OR-A5JH-01A M0 Cytoplasm presence <= 25% Present -11994 1811 0 2110 Diffuse Architecture Present None 2014-6-11 FEMALE NO Adrenocortical Carcinoma- Oncocytic Type No C74.0 8370/3 C74.0 YES 20 Invasion of Tumor Capsule Absent NO Left NO 1 NO Mitotic Rate > 5/50 HPF Absent Necrosis Present NO Nuclear Grade III or IV Present true No N0 T2 Stage II TCGA-OR-A5JH.CF498A30-11FC-4F20-A424-E3A1216D54B2.pdf A5JH TUMOR FREE No imaging evidence of disease NO Complete Remission/Response NO R0 Primary Tumor 01 Sinusoid Invasion Absent NO YES OR Adrenal A LIVING 4 Venous Invasion Absent 2008 TCGA-OR-A5JH-01A-11D-A30A-10 TCGA-OR-A5JH-01A-11D-A309-01 TCGA-OR-A5JH-01A-11D-A309-01 TCGA-OR-A5JH-01A-11D-A30A-10 TCGA-OR-A5JH-01A-11D-A30A-10 +TCGA-OR-A5JI-01 TCGA-OR-A5JI-01 TCGA-OR-A5JI TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 22 Atypical Mitotic Figures Absent TCGA-OR-A5JI-F71753 TCGA-OR-A5JI M0 Normal Cytoplasm presence <= 25% Present -8177 0 2331 Diffuse Architecture Present None 2015-3-30 MALE NO Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES Invasion of Tumor Capsule Absent Right NO 1 NO NO Mitotic Rate > 5/50 HPF Absent Necrosis Absent NO Nuclear Grade III or IV Present No N0 T1 Stage I A5JI TUMOR FREE No imaging evidence of disease NO NO Complete Remission/Response NO R0 Primary Tumor 01 Sinusoid Invasion Absent NO YES OR Adrenal LIVING 3 Venous Invasion Absent 2008 TCGA-OR-A5JI-01A-11D-A29I-10 d5a1b1c5-f790-4733-a8f5-09372d695688 TCGA-OR-A5JI-01 TCGA-OR-A5JI-01 TCGA-OR-A5JI-01A-11D-A29J-05 d5a1b1c5-f790-4733-a8f5-09372d695688 d5a1b1c5-f790-4733-a8f5-09372d695688 TCGA-OR-A5JI-01A-11D-A29H-01 TCGA-OR-A5JI-01 TCGA-OR-A5JI-01 d5a1b1c5-f790-4733-a8f5-09372d695688 TCGA-OR-A5JI-01A-11D-A29H-01 TCGA-OR-A5JI-01A-11D-A29I-10 TCGA-OR-A5JI-01A-11D-A29I-10 +TCGA-OR-A5JJ-01 TCGA-OR-A5JJ-01 TCGA-OR-A5JJ TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 65 Atypical Mitotic Figures Present TCGA-OR-A5JJ-F60575 TCGA-OR-A5JJ TCGA-OR-A5JJ-01A M1 Lung Involvement Cytoplasm presence <= 25% Present -24082 1308 490 0 309 Diffuse Architecture Present None 2014-6-11 MALE YES Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 40 Invasion of Tumor Capsule Present NO Left NO 6 50 YES YES Mitotic Rate > 5/50 HPF Present Necrosis Present NO Nuclear Grade III or IV Present 6 true No N1 T4 Stage IV TCGA-OR-A5JJ.AF7A85AB-4C73-40B8-B913-9E540FEDE0FC.pdf A5JJ WITH TUMOR Persistent distant metastases YES YES Progressive Disease NO R2 Primary Tumor 01 Sinusoid Invasion Present NO NO YES OR Adrenal A DECEASED 9 Venous Invasion Present 2009 TCGA-OR-A5JJ-01A-11D-A29I-10 39336e11-24de-43be-913a-c764310d1eee TCGA-OR-A5JJ-01 TCGA-OR-A5JJ-01 TCGA-OR-A5JJ-01A-11D-A29J-05 39336e11-24de-43be-913a-c764310d1eee 39336e11-24de-43be-913a-c764310d1eee TCGA-OR-A5JJ-01A-11D-A29H-01 TCGA-OR-A5JJ-01 TCGA-OR-A5JJ-01 39336e11-24de-43be-913a-c764310d1eee TCGA-OR-A5JJ-01A-11D-A29H-01 TCGA-OR-A5JJ-01A-11D-A29I-10 TCGA-OR-A5JJ-01A-11D-A29I-10 +TCGA-OR-A5JK-01 TCGA-OR-A5JK-01 TCGA-OR-A5JK TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 49 Atypical Mitotic Figures Present TCGA-OR-A5JK-F60576 TCGA-OR-A5JK M1 Lung Involvement Cytoplasm presence <= 25% Present -18214 0 1497 Diffuse Architecture Present None 2014-6-11 MALE NO Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES Invasion of Tumor Capsule Present Left NO Biopsy Proven 4 YES YES Mitotic Rate > 5/50 HPF Absent Necrosis Present NO Nuclear Grade III or IV Present No N0 T4 Stage IV A5JK TUMOR FREE Persistent distant metastases YES Partial Remission/Response YES R2 Primary Tumor 01 Sinusoid Invasion Present YES NO YES OR Adrenal LIVING 8 Venous Invasion Present 2009 TCGA-OR-A5JK-01A-11D-A29I-10 db5bc4cb-f0bc-4c26-bd11-1bf918466263 TCGA-OR-A5JK-01 TCGA-OR-A5JK-01 TCGA-OR-A5JK-01A-11D-A29J-05 db5bc4cb-f0bc-4c26-bd11-1bf918466263 db5bc4cb-f0bc-4c26-bd11-1bf918466263 TCGA-OR-A5JK-01A-11D-A29H-01 TCGA-OR-A5JK-01 TCGA-OR-A5JK-01 db5bc4cb-f0bc-4c26-bd11-1bf918466263 TCGA-OR-A5JK-01A-11D-A29H-01 TCGA-OR-A5JK-01A-11D-A29I-10 TCGA-OR-A5JK-01A-11D-A29I-10 +TCGA-OR-A5JL-01 TCGA-OR-A5JL-01 TCGA-OR-A5JL TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 36 Atypical Mitotic Figures Present TCGA-OR-A5JL-F71754 TCGA-OR-A5JL TCGA-OR-A5JL-01A M0 Normal Cytoplasm presence <= 25% Present -13155 1224 0 2056 Diffuse Architecture Present Both Clinical and Biochemical Assessments Androgen 2015-3-30 FEMALE NO Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 60 Invasion of Tumor Capsule Absent NO Right NO 6 YES YES Mitotic Rate > 5/50 HPF Present Necrosis Absent NO Nuclear Grade III or IV Present true No N0 T1 Stage I TCGA-OR-A5JL.BD8435C3-C525-472C-8B43-EC2CAE22B785.pdf A5JL TUMOR FREE No imaging evidence of disease YES NO Complete Remission/Response NO R0 Primary Tumor 01 Sinusoid Invasion Absent YES NO YES OR Adrenal A LIVING 5 Venous Invasion Absent 2009 TCGA-OR-A5JL-01A-11D-A29I-10 3e28c232-4f00-446e-8e2c-13b7ce533442 TCGA-OR-A5JL-01 TCGA-OR-A5JL-01 TCGA-OR-A5JL-01A-11D-A29J-05 3e28c232-4f00-446e-8e2c-13b7ce533442 3e28c232-4f00-446e-8e2c-13b7ce533442 TCGA-OR-A5JL-01A-11D-A29H-01 TCGA-OR-A5JL-01 TCGA-OR-A5JL-01 3e28c232-4f00-446e-8e2c-13b7ce533442 TCGA-OR-A5JL-01A-11D-A29H-01 TCGA-OR-A5JL-01A-11D-A29I-10 TCGA-OR-A5JL-01A-11D-A29I-10 +TCGA-OR-A5JM-01 TCGA-OR-A5JM-01 TCGA-OR-A5JM TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 25 Atypical Mitotic Figures Present TCGA-OR-A5JM TCGA-OR-A5JM-01A M1 Liver Involvement Cytoplasm presence <= 25% Present -9359 657 562 0 Diffuse Architecture Present Both Clinical and Biochemical Assessments Cortisol 2013-10-3 FEMALE NO Adrenocortical carcinoma- Usual Type Yes C74.0 8370/3 C74.0 YES 70 Invasion of Tumor Capsule Present NO Left Other, specify 90 YES YES Mitotic Rate > 5/50 HPF Present Necrosis Present YES Nuclear Grade III or IV Present true No N0 T4 Stage IV TCGA-OR-A5JM.A214150E-54BD-499D-A56D-082BAC861668.pdf A5JM WITH TUMOR Biochemical Evidence of Disease YES Progressive Disease YES R1 Primary Tumor 01 Sinusoid Invasion Present NO YES OR Adrenal A DECEASED 9 Venous Invasion Present 2011 TCGA-OR-A5JM-01A-11D-A29I-10 908285b8-1e2e-4aed-86df-2aaeb1bcefea TCGA-OR-A5JM-01 TCGA-OR-A5JM-01 TCGA-OR-A5JM-01A-11D-A29J-05 908285b8-1e2e-4aed-86df-2aaeb1bcefea 908285b8-1e2e-4aed-86df-2aaeb1bcefea TCGA-OR-A5JM-01A-11D-A29H-01 TCGA-OR-A5JM-01 TCGA-OR-A5JM-01 908285b8-1e2e-4aed-86df-2aaeb1bcefea TCGA-OR-A5JM-01A-11D-A29H-01 TCGA-OR-A5JM-01A-11D-A29I-10 TCGA-OR-A5JM-01A-11D-A29I-10 +TCGA-OR-A5JO-01 TCGA-OR-A5JO-01 TCGA-OR-A5JO TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 26 Atypical Mitotic Figures Absent TCGA-OR-A5JO-F71755 TCGA-OR-A5JO M0 Normal Cytoplasm presence <= 25% Absent -9547 0 1194 Diffuse Architecture Present None 2015-3-30 FEMALE NO Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES Invasion of Tumor Capsule Absent Right NO 2 NO NO Mitotic Rate > 5/50 HPF Absent Necrosis Absent NO Nuclear Grade III or IV Present No N0 T1 Stage I A5JO TUMOR FREE No imaging evidence of disease NO NO Complete Remission/Response NO R0 Primary Tumor 01 Sinusoid Invasion Absent NO YES OR Adrenal LIVING 3 Venous Invasion Present 2005 TCGA-OR-A5JO-01A-11D-A29I-10 ebc120e7-d75d-425a-b9af-aa0e76520642 TCGA-OR-A5JO-01 TCGA-OR-A5JO-01 TCGA-OR-A5JO-01A-11D-A29J-05 ebc120e7-d75d-425a-b9af-aa0e76520642 ebc120e7-d75d-425a-b9af-aa0e76520642 TCGA-OR-A5JO-01A-11D-A29H-01 TCGA-OR-A5JO-01 TCGA-OR-A5JO-01 ebc120e7-d75d-425a-b9af-aa0e76520642 TCGA-OR-A5JO-01A-11D-A29H-01 TCGA-OR-A5JO-01A-11D-A29I-10 TCGA-OR-A5JO-01A-11D-A29I-10 +TCGA-OR-A5JP-01 TCGA-OR-A5JP-01 TCGA-OR-A5JP TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 40 Atypical Mitotic Figures Present TCGA-OR-A5JP-F60579 TCGA-OR-A5JP TCGA-OR-A5JP-01A M0 Normal Cytoplasm presence <= 25% Present -14667 289 0 464 Diffuse Architecture Present None 2014-6-11 MALE NO Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 60 Invasion of Tumor Capsule Absent NO Left NO 13 YES YES Mitotic Rate > 5/50 HPF Present Necrosis Present NO Nuclear Grade III or IV Present true No N0 T2 Stage II TCGA-OR-A5JP.E7B0A3CF-35A3-433C-AF76-DB3E28DA6A46.pdf A5JP TUMOR FREE No imaging evidence of disease YES NO Complete Remission/Response NO R0 Primary Tumor 01 Sinusoid Invasion Absent YES NO YES OR Adrenal A LIVING 6 Venous Invasion Absent 2012 TCGA-OR-A5JP-01A-11D-A29I-10 49e3ffbc-f75f-4f3d-99de-12c29ef69154 TCGA-OR-A5JP-01 TCGA-OR-A5JP-01 FD2E1526-5455-40FA-8AE2-15C5FF2BAA65 TCGA-OR-A5JP-01A-11D-A29J-05 49e3ffbc-f75f-4f3d-99de-12c29ef69154 49e3ffbc-f75f-4f3d-99de-12c29ef69154 TCGA-OR-A5JP-01A-11D-A29H-01 TCGA-OR-A5JP-01 TCGA-OR-A5JP-01 49e3ffbc-f75f-4f3d-99de-12c29ef69154 TCGA-OR-A5JP-01A-11D-A29H-01 TCGA-OR-A5JP-01A-11D-A29I-10 TCGA-OR-A5JP-01A-11D-A29I-10 +TCGA-OR-A5JQ-01 TCGA-OR-A5JQ-01 TCGA-OR-A5JQ TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 26 Atypical Mitotic Figures Absent TCGA-OR-A5JQ-F60580 TCGA-OR-A5JQ M0 Normal Cytoplasm presence <= 25% Present -9667 0 1103 Diffuse Architecture Present None 2014-6-11 FEMALE NO Adrenocortical Carcinoma- Myxoid Type No C74.0 8370/3 C74.0 YES Invasion of Tumor Capsule Absent Right NO 3 NO NO Mitotic Rate > 5/50 HPF Absent Necrosis Absent NO Nuclear Grade III or IV Present No N0 T2 Stage II A5JQ TUMOR FREE No imaging evidence of disease NO NO Complete Remission/Response NO R0 Primary Tumor 01 Sinusoid Invasion Present NO YES OR Adrenal LIVING 4 Venous Invasion Absent 2006 TCGA-OR-A5JQ-01A-11D-A29I-10 f0461f9a-e85e-42c6-8f4b-e5974a0e78f8 TCGA-OR-A5JQ-01 TCGA-OR-A5JQ-01 TCGA-OR-A5JQ-01A-11D-A29J-05 f0461f9a-e85e-42c6-8f4b-e5974a0e78f8 f0461f9a-e85e-42c6-8f4b-e5974a0e78f8 TCGA-OR-A5JQ-01A-11D-A29H-01 TCGA-OR-A5JQ-01 TCGA-OR-A5JQ-01 f0461f9a-e85e-42c6-8f4b-e5974a0e78f8 TCGA-OR-A5JQ-01A-11D-A29H-01 TCGA-OR-A5JQ-01A-11D-A29I-10 TCGA-OR-A5JQ-01A-11D-A29I-10 +TCGA-OR-A5JR-01 TCGA-OR-A5JR-01 TCGA-OR-A5JR TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 45 TCGA-OR-A5JR-F59158 TCGA-OR-A5JR TCGA-OR-A5JR-01A M0 -16604 3751 0 3688 Diffuse Architecture Absent None 2014-5-2 MALE YES Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 80 Invasion of Tumor Capsule Present NO Left YES NO Necrosis Absent NO Nuclear Grade III or IV Absent false No N0 T1 Stage I TCGA-OR-A5JR.33E0DEF4-2538-4C8B-A71C-11B4F9D57E32.pdf A5JR TUMOR FREE No imaging evidence of disease NO NO Complete Remission/Response NO R0 Primary Tumor 01 Sinusoid Invasion Absent NO YES OR Adrenal A LIVING Venous Invasion Absent 2002 TCGA-OR-A5JR-01A-11D-A29I-10 cc3d79b1-66a4-4f17-bdb1-c91ffab17037 TCGA-OR-A5JR-01 TCGA-OR-A5JR-01 8DCC0B31-4CD4-4537-8BC1-C928F1E5BB29 TCGA-OR-A5JR-01A-11D-A29J-05 cc3d79b1-66a4-4f17-bdb1-c91ffab17037 cc3d79b1-66a4-4f17-bdb1-c91ffab17037 TCGA-OR-A5JR-01A-11D-A29H-01 TCGA-OR-A5JR-01 TCGA-OR-A5JR-01 cc3d79b1-66a4-4f17-bdb1-c91ffab17037 TCGA-OR-A5JR-01A-11D-A29H-01 TCGA-OR-A5JR-01A-11D-A29I-10 TCGA-OR-A5JR-01A-11D-A29I-10 +TCGA-OR-A5JS-01 TCGA-OR-A5JS-01 TCGA-OR-A5JS TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland YES NO 65 TCGA-OR-A5JS-F59160 TCGA-OR-A5JS TCGA-OR-A5JS-01A M0 Normal -24017 699 0 383 166 None 2014-5-2 FEMALE NO Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 150 Invasion of Tumor Capsule Absent NO Right YES 35 NO Mitotic Rate > 5/50 HPF Present Necrosis Present Imaging Lung Distant Metastasis NO YES false No N0 T2 Stage II TCGA-OR-A5JS.B6E65697-5AE8-45B4-9FAA-D25B8F57988F.pdf A5JS WITH TUMOR No imaging evidence of disease NO NO YES R0 Primary Tumor 01 NO YES OR Adrenal A LIVING 2011 TCGA-OR-A5JS-01A-11D-A29I-10 68b2e310-e0a0-4867-b9cf-69b43cbdabce TCGA-OR-A5JS-01 TCGA-OR-A5JS-01 D187AC75-482F-454F-851A-10A7ABEBA2BF TCGA-OR-A5JS-01A-11D-A29J-05 68b2e310-e0a0-4867-b9cf-69b43cbdabce 68b2e310-e0a0-4867-b9cf-69b43cbdabce TCGA-OR-A5JS-01A-11D-A29H-01 TCGA-OR-A5JS-01 TCGA-OR-A5JS-01 68b2e310-e0a0-4867-b9cf-69b43cbdabce TCGA-OR-A5JS-01A-11D-A29H-01 TCGA-OR-A5JS-01A-11D-A29I-10 TCGA-OR-A5JS-01A-11D-A29I-10 +TCGA-OR-A5JT-01 TCGA-OR-A5JT-01 TCGA-OR-A5JT TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 65 TCGA-OR-A5JT-F59161 TCGA-OR-A5JT TCGA-OR-A5JT-01A M0 Normal -23794 419 0 907 Biochemical Assessment Cortisol 2014-5-1 FEMALE YES Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 140 Invasion of Tumor Capsule Absent NO Left NO 17 5 YES YES Mitotic Rate > 5/50 HPF Absent Necrosis Present NO 0 false No N0 T2 Stage II TCGA-OR-A5JT.095AE671-9808-4895-B6FD-EDA3F7F9E69D.pdf A5JT WITH TUMOR No imaging evidence of disease YES YES Stable Disease YES R0 Primary Tumor 01 YES YES NO YES OR Adrenal A LIVING Venous Invasion Absent 2011 TCGA-OR-A5JT-01A-11D-A29I-10 36c36f8f-d15b-43be-a285-1f80fcfff555 TCGA-OR-A5JT-01 TCGA-OR-A5JT-01 C9D2DE61-07C2-4BE8-832F-D4D95749A075 TCGA-OR-A5JT-01A-11D-A29J-05 36c36f8f-d15b-43be-a285-1f80fcfff555 36c36f8f-d15b-43be-a285-1f80fcfff555 TCGA-OR-A5JT-01A-11D-A29H-01 TCGA-OR-A5JT-01 TCGA-OR-A5JT-01 36c36f8f-d15b-43be-a285-1f80fcfff555 TCGA-OR-A5JT-01A-11D-A29H-01 TCGA-OR-A5JT-01A-11D-A29I-10 TCGA-OR-A5JT-01A-11D-A29I-10 +TCGA-OR-A5JU-01 TCGA-OR-A5JU-01 TCGA-OR-A5JU TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 58 TCGA-OR-A5JU TCGA-OR-A5JU-01A M0 Normal -21292 749 289 0 None 2014-2-6 FEMALE YES Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 130 Invasion of Tumor Capsule Present NO Right 10 YES YES NO Mitotic Rate > 5/50 HPF Present Necrosis Absent YES false No N0 T3 Stage III TCGA-OR-A5JU.2D791779-66E6-408C-B479-CC74246F0EA8.pdf A5JU WITH TUMOR No imaging evidence of disease YES NO Progressive Disease YES R0 Primary Tumor 01 NO YES OR Adrenal A DECEASED Venous Invasion Absent 2010 TCGA-OR-A5JU-01A-11D-A30A-10 TCGA-OR-A5JU-01A-11D-A309-01 TCGA-OR-A5JU-01A-11D-A309-01 TCGA-OR-A5JU-01A-11D-A30A-10 TCGA-OR-A5JU-01A-11D-A30A-10 +TCGA-OR-A5JV-01 TCGA-OR-A5JV-01 TCGA-OR-A5JV TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 55 TCGA-OR-A5JV-F59162 TCGA-OR-A5JV TCGA-OR-A5JV-01A M0 Normal -20319 1696 0 2023 None 2014-5-1 MALE Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 110 Invasion of Tumor Capsule Absent NO Left NO 1 YES YES Necrosis Absent NO 0 false No N0 T2 Stage II TCGA-OR-A5JV.35A41AE5-44E3-45D1-A2C0-523496732A75.pdf A5JV TUMOR FREE No imaging evidence of disease YES YES Complete Remission/Response NO R0 Primary Tumor 01 YES NO NO YES OR Adrenal A LIVING Venous Invasion Absent 2008 TCGA-OR-A5JV-01A-11D-A29I-10 20938e21-2846-4553-98eb-6b005b6600c3 TCGA-OR-A5JV-01 TCGA-OR-A5JV-01 148E70D8-63E9-421C-9D54-EB905B6EE954 TCGA-OR-A5JV-01A-11D-A29J-05 20938e21-2846-4553-98eb-6b005b6600c3 20938e21-2846-4553-98eb-6b005b6600c3 TCGA-OR-A5JV-01A-11D-A29H-01 TCGA-OR-A5JV-01 TCGA-OR-A5JV-01 20938e21-2846-4553-98eb-6b005b6600c3 TCGA-OR-A5JV-01A-11D-A29H-01 TCGA-OR-A5JV-01A-11D-A29I-10 TCGA-OR-A5JV-01A-11D-A29I-10 +TCGA-OR-A5JW-01 TCGA-OR-A5JW-01 TCGA-OR-A5JW TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 47 TCGA-OR-A5JW-F59163 TCGA-OR-A5JW TCGA-OR-A5JW-01A M0 Normal -17513 1713 0 2202 Both Clinical and Biochemical Assessments Cortisol 2014-5-1 MALE Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 140 NO Right NO YES YES Necrosis Present NO false No N0 T2 Stage II TCGA-OR-A5JW.54BAF12C-F096-4415-BFF0-DD35D22E932B.pdf A5JW TUMOR FREE No imaging evidence of disease YES NO Complete Remission/Response YES R0 Primary Tumor 01 YES NO YES OR Adrenal A LIVING 2008 TCGA-OR-A5JW-01A-11D-A29I-10 a499a77e-4584-4cab-a7d9-3d0b42ed4dd8 TCGA-OR-A5JW-01 TCGA-OR-A5JW-01 7ABAE497-21E0-4DA6-B835-5E60E4E2878F TCGA-OR-A5JW-01A-11D-A29J-05 a499a77e-4584-4cab-a7d9-3d0b42ed4dd8 a499a77e-4584-4cab-a7d9-3d0b42ed4dd8 TCGA-OR-A5JW-01A-11D-A29H-01 TCGA-OR-A5JW-01 TCGA-OR-A5JW-01 a499a77e-4584-4cab-a7d9-3d0b42ed4dd8 TCGA-OR-A5JW-01A-11D-A29H-01 TCGA-OR-A5JW-01A-11D-A29I-10 TCGA-OR-A5JW-01A-11D-A29I-10 +TCGA-OR-A5JX-01 TCGA-OR-A5JX-01 TCGA-OR-A5JX TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 50 TCGA-OR-A5JX-F59164 TCGA-OR-A5JX TCGA-OR-A5JX-01A M0 -18402 1162 0 950 None 2014-5-2 MALE YES Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 120 Invasion of Tumor Capsule Present NO Left YES 1 5 YES YES Mitotic Rate > 5/50 HPF Absent Necrosis Present NO 0 false No N0 T3 Stage III TCGA-OR-A5JX.6F548B5E-C4A2-46C7-8B56-7DD037CC49B5.pdf A5JX TUMOR FREE No imaging evidence of disease YES YES YES R0 Primary Tumor 01 YES NO NO YES OR Adrenal A LIVING Venous Invasion Present 2009 TCGA-OR-A5JX-01A-11D-A29I-10 7fae0485-2028-47e3-a3e1-248257fcc02e TCGA-OR-A5JX-01 TCGA-OR-A5JX-01 TCGA-OR-A5JX-01A-11D-A29J-05 7fae0485-2028-47e3-a3e1-248257fcc02e 7fae0485-2028-47e3-a3e1-248257fcc02e TCGA-OR-A5JX-01A-11D-A29H-01 TCGA-OR-A5JX-01 TCGA-OR-A5JX-01 7fae0485-2028-47e3-a3e1-248257fcc02e TCGA-OR-A5JX-01A-11D-A29H-01 TCGA-OR-A5JX-01A-11D-A29I-10 TCGA-OR-A5JX-01A-11D-A29I-10 +TCGA-OR-A5JY-01 TCGA-OR-A5JY-01 TCGA-OR-A5JY TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 68 TCGA-OR-A5JY TCGA-OR-A5JY-01A M1 Vena Cava Involvement/thrombus -25190 414 552 0 Both Clinical and Biochemical Assessments Androgen|Cortisol 2013-9-10 FEMALE Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 190 Invasion of Tumor Capsule Present NO Right 2 Other, specify surgical resection 60 YES NO YES Mitotic Rate > 5/50 HPF Present Necrosis Present YES 1 false No N1 T4 Stage IV TCGA-OR-A5JY.8D4E0E4D-9C84-4F29-AFD9-91EEEC158ED6.pdf A5JY WITH TUMOR Persistent distant metastases YES YES Progressive Disease YES R2 Primary Tumor 01 NO NO YES OR Adrenal A DECEASED Venous Invasion Present 2011 TCGA-OR-A5JY-01A-31D-A29I-10 1fe73f5c-591d-4c55-ae0e-a67afb64f872 TCGA-OR-A5JY-01 TCGA-OR-A5JY-01 A4ABDBE6-DB86-40C9-8E65-E772D0B6AB28 TCGA-OR-A5JY-01A-31D-A29J-05 1fe73f5c-591d-4c55-ae0e-a67afb64f872 1fe73f5c-591d-4c55-ae0e-a67afb64f872 TCGA-OR-A5JY-01A-31D-A29H-01 TCGA-OR-A5JY-01 TCGA-OR-A5JY-01 1fe73f5c-591d-4c55-ae0e-a67afb64f872 TCGA-OR-A5JY-01A-31D-A29H-01 TCGA-OR-A5JY-01A-31D-A29I-10 TCGA-OR-A5JY-01A-31D-A29I-10 +TCGA-OR-A5JZ-01 TCGA-OR-A5JZ-01 TCGA-OR-A5JZ TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland YES NO 60 TCGA-OR-A5JZ-F59165 TCGA-OR-A5JZ TCGA-OR-A5JZ-01A M0 Normal -22218 373 0 822 247 None 2014-5-1 MALE YES Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 130 Invasion of Tumor Capsule Present NO Left NO 5 YES YES Mitotic Rate > 5/50 HPF Absent Necrosis Present Imaging Liver Distant Metastasis NO YES false No N0 T2 Stage II TCGA-OR-A5JZ.90A9556D-C417-4FDB-AE1C-7ACB9F60E444.pdf A5JZ WITH TUMOR No imaging evidence of disease YES NO Progressive Disease YES R0 Primary Tumor 01 NO NO YES OR Adrenal A LIVING Venous Invasion Absent 2011 TCGA-OR-A5JZ-01A-11D-A29I-10 efd8ce67-122c-4502-8713-2f4dd768c33d TCGA-OR-A5JZ-01 TCGA-OR-A5JZ-01 47A9E07A-5319-4550-98C8-B48E1785E8B9 TCGA-OR-A5JZ-01A-11D-A29J-05 efd8ce67-122c-4502-8713-2f4dd768c33d efd8ce67-122c-4502-8713-2f4dd768c33d TCGA-OR-A5JZ-01A-11D-A29H-01 TCGA-OR-A5JZ-01 TCGA-OR-A5JZ-01 efd8ce67-122c-4502-8713-2f4dd768c33d TCGA-OR-A5JZ-01A-11D-A29H-01 TCGA-OR-A5JZ-01A-11D-A29I-10 TCGA-OR-A5JZ-01A-11D-A29I-10 +TCGA-OR-A5K0-01 TCGA-OR-A5K0-01 TCGA-OR-A5K0 TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 69 TCGA-OR-A5K0-F59166 TCGA-OR-A5K0 TCGA-OR-A5K0-01A M0 Normal -25400 1097 0 1029 Biochemical Assessment Cortisol 2014-5-2 FEMALE Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 200 Invasion of Tumor Capsule Present NO Left YES 8 NO Mitotic Rate > 5/50 HPF Present Necrosis Present YES false Yes N0 T2 Stage II TCGA-OR-A5K0.4E5C6CF0-F346-4ECE-B296-0D2DB4513804.pdf A5K0 WITH TUMOR No imaging evidence of disease NO NO Progressive Disease NO R0 Primary Tumor 01 NO YES OR Adrenal A LIVING Venous Invasion Absent 2009 TCGA-OR-A5K0-01A-11D-A29I-10 e1434398-dde0-4855-adc1-24c2956d817a TCGA-OR-A5K0-01 TCGA-OR-A5K0-01 0C923154-7872-4AEE-A56A-085CCD06E6BC TCGA-OR-A5K0-01A-11D-A29J-05 e1434398-dde0-4855-adc1-24c2956d817a e1434398-dde0-4855-adc1-24c2956d817a TCGA-OR-A5K0-01A-11D-A29H-01 TCGA-OR-A5K0-01 TCGA-OR-A5K0-01 e1434398-dde0-4855-adc1-24c2956d817a TCGA-OR-A5K0-01A-11D-A29H-01 TCGA-OR-A5K0-01A-11D-A29I-10 TCGA-OR-A5K0-01A-11D-A29I-10 +TCGA-OR-A5K1-01 TCGA-OR-A5K1-01 TCGA-OR-A5K1 TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland NO YES 48 TCGA-OR-A5K1-F71436 TCGA-OR-A5K1 TCGA-OR-A5K1-01A M0 Retroperitoneal Lymph Node Involvement -17596 2513 0 3289 883 826 None 2015-3-25 MALE Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 150 Invasion of Tumor Capsule Present NO Left NO NO NO Imaging Peritoneal Surfaces Locoregional Recurrence YES YES false No N0 T2 Stage II TCGA-OR-A5K1.54EFE89F-32E0-4E95-A841-728648D9D11E.pdf A5K1 TUMOR FREE No imaging evidence of disease NO NO Complete Remission/Response NO RX Primary Tumor 01 NO YES OR Adrenal A LIVING 2006 TCGA-OR-A5K1-01A-11D-A29I-10 b6c575a4-ebbc-413d-955d-bb3c46ec50c2 TCGA-OR-A5K1-01 TCGA-OR-A5K1-01 3C6CBE32-CF86-40FC-BF24-560A66EF7CC6 TCGA-OR-A5K1-01A-11D-A29J-05 b6c575a4-ebbc-413d-955d-bb3c46ec50c2 b6c575a4-ebbc-413d-955d-bb3c46ec50c2 TCGA-OR-A5K1-01A-11D-A29H-01 TCGA-OR-A5K1-01 TCGA-OR-A5K1-01 b6c575a4-ebbc-413d-955d-bb3c46ec50c2 TCGA-OR-A5K1-01A-11D-A29H-01 TCGA-OR-A5K1-01A-11D-A29I-10 TCGA-OR-A5K1-01A-11D-A29I-10 +TCGA-OR-A5K2-01 TCGA-OR-A5K2-01 TCGA-OR-A5K2 TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 32 TCGA-OR-A5K2 M0 Normal -11970 994 0 Both Clinical and Biochemical Assessments Androgen|Cortisol 2013-9-10 FEMALE YES Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES Invasion of Tumor Capsule Present Right 1 Imaging Suspected 51 YES YES YES Mitotic Rate > 5/50 HPF Present Necrosis Present YES 0 No N0 T4 Stage III A5K2 WITH TUMOR Persistent distant metastases YES YES Progressive Disease YES R0 Primary Tumor 01 YES NO NO YES OR Adrenal DECEASED Venous Invasion Present 2010 e85fc5ec-7838-46c3-8767-a69f765b066d TCGA-OR-A5K2-01 TCGA-OR-A5K2-01 TCGA-OR-A5K2-01A-11D-A29J-05 e85fc5ec-7838-46c3-8767-a69f765b066d e85fc5ec-7838-46c3-8767-a69f765b066d TCGA-OR-A5K2-01A-11D-A29H-01 TCGA-OR-A5K2-01 TCGA-OR-A5K2-01 e85fc5ec-7838-46c3-8767-a69f765b066d TCGA-OR-A5K2-01A-11D-A29H-01 TCGA-OR-A5K2-01A-11D-A29I-10 TCGA-OR-A5K2-01A-11D-A29I-10 +TCGA-OR-A5K3-01 TCGA-OR-A5K3-01 TCGA-OR-A5K3 TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 53 TCGA-OR-A5K3-F71438 TCGA-OR-A5K3 TCGA-OR-A5K3-01A M0 Normal -19375 2646 0 3465 None 2015-3-25 MALE NO Adrenocortical Carcinoma- Oncocytic Type No C74.0 8370/3 C74.0 YES 110 Invasion of Tumor Capsule Present NO Left NO NO NO Necrosis Present NO false No N0 T2 Stage II TCGA-OR-A5K3.718C16E9-A099-4F21-A48E-A97B464A9422.pdf A5K3 TUMOR FREE No imaging evidence of disease NO NO Complete Remission/Response NO R0 Primary Tumor 01 NO YES OR Adrenal A LIVING 2005 61d60013-6ffd-4c08-b03f-a8820db32397 TCGA-OR-A5K3-01 TCGA-OR-A5K3-01 08E6497A-47F5-4283-A534-7C04EEC936E9 TCGA-OR-A5K3-01A-11D-A29J-05 61d60013-6ffd-4c08-b03f-a8820db32397 61d60013-6ffd-4c08-b03f-a8820db32397 TCGA-OR-A5K3-01A-11D-A29H-01 TCGA-OR-A5K3-01 TCGA-OR-A5K3-01 61d60013-6ffd-4c08-b03f-a8820db32397 TCGA-OR-A5K3-01A-11D-A29H-01 TCGA-OR-A5K3-01A-11D-A29I-10 TCGA-OR-A5K3-01A-11D-A29I-10 +TCGA-OR-A5K4-01 TCGA-OR-A5K4-01 TCGA-OR-A5K4 TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 64 TCGA-OR-A5K4-F71439 TCGA-OR-A5K4 TCGA-OR-A5K4-01A M0 Vena Cava Involvement/thrombus -23481 362 0 1082 None 2015-3-25 FEMALE YES Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 190 Invasion of Tumor Capsule Absent NO Right NO 2 YES YES Mitotic Rate > 5/50 HPF Absent Necrosis Present NO false No N0 T4 Stage III TCGA-OR-A5K4.15A731FD-6B89-450D-A02B-A01DA759340A.pdf A5K4 TUMOR FREE No imaging evidence of disease YES NO Complete Remission/Response YES R1 Primary Tumor 01 NO NO YES OR Adrenal A LIVING Venous Invasion Present 2011 TCGA-OR-A5K4-01A-11D-A29I-10 5c9ae88c-353f-450b-80e6-8d36d7bc8be3 TCGA-OR-A5K4-01 TCGA-OR-A5K4-01 A2831971-C497-4E23-A84C-B2D64B21E72C TCGA-OR-A5K4-01A-11D-A29J-05 5c9ae88c-353f-450b-80e6-8d36d7bc8be3 5c9ae88c-353f-450b-80e6-8d36d7bc8be3 TCGA-OR-A5K4-01A-11D-A29H-01 TCGA-OR-A5K4-01 TCGA-OR-A5K4-01 5c9ae88c-353f-450b-80e6-8d36d7bc8be3 TCGA-OR-A5K4-01A-11D-A29H-01 TCGA-OR-A5K4-01A-11D-A29I-10 TCGA-OR-A5K4-01A-11D-A29I-10 +TCGA-OR-A5K5-01 TCGA-OR-A5K5-01 TCGA-OR-A5K5 TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland YES NO 59 TCGA-OR-A5K5-F59170 TCGA-OR-A5K5 TCGA-OR-A5K5-01A M0 Normal -21907 34 498 0 253 108 Both Clinical and Biochemical Assessments Androgen|Cortisol 2014-5-1 FEMALE YES NO Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 120 Invasion of Tumor Capsule Present NO Left NO 20 31 YES YES Mitotic Rate > 5/50 HPF Present Necrosis Present Imaging Lung Distant Metastasis NO YES 0 false No N0 T3 Stage III TCGA-OR-A5K5.6EA3FB77-3DD4-43C8-8C39-CA8755EBC50C.pdf A5K5 WITH TUMOR YES YES Progressive Disease YES R0 Primary Tumor 01 YES NO NO YES OR Adrenal A DECEASED Venous Invasion Present 2012 TCGA-OR-A5K5-01A-11D-A29I-10 c70685d2-1d32-44f9-9ce6-e44b229e0bb0 TCGA-OR-A5K5-01 TCGA-OR-A5K5-01 D0C57FBD-20EE-4113-A135-7B7617304C0F TCGA-OR-A5K5-01A-11D-A29J-05 c70685d2-1d32-44f9-9ce6-e44b229e0bb0 c70685d2-1d32-44f9-9ce6-e44b229e0bb0 TCGA-OR-A5K5-01A-11D-A29H-01 TCGA-OR-A5K5-01 TCGA-OR-A5K5-01 c70685d2-1d32-44f9-9ce6-e44b229e0bb0 TCGA-OR-A5K5-01A-11D-A29H-01 TCGA-OR-A5K5-01A-11D-A29I-10 TCGA-OR-A5K5-01A-11D-A29I-10 +TCGA-OR-A5K6-01 TCGA-OR-A5K6-01 TCGA-OR-A5K6 TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland YES NO 56 Atypical Mitotic Figures Present TCGA-OR-A5K6-F61830 TCGA-OR-A5K6 TCGA-OR-A5K6-01A M0 Normal Cytoplasm presence <= 25% Present -20657 946 0 1493 1003 391 Diffuse Architecture Absent Both Clinical and Biochemical Assessments Cortisol 2014-7-8 FEMALE YES Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 120 Invasion of Tumor Capsule Absent NO Left NO 7 YES NO YES Mitotic Rate > 5/50 HPF Present Necrosis Present Pathology Liver Distant Metastasis YES YES Nuclear Grade III or IV Present false No N0 T2 Stage II TCGA-OR-A5K6.CB9B68D7-762B-4828-9479-4ECFE346AB5C.pdf A5K6 WITH TUMOR No imaging evidence of disease YES NO Complete Remission/Response NO R0 Primary Tumor 01 Sinusoid Invasion Absent YES YES YES NO OR Adrenal A LIVING 5 Venous Invasion Absent 2010 TCGA-OR-A5K6-01A-11D-A29I-10 eeda9161-2cf5-4ae2-b8ca-99bd13c053e4 TCGA-OR-A5K6-01 TCGA-OR-A5K6-01 1A7C62C2-00E2-415E-9C4F-318297C57ECE TCGA-OR-A5K6-01A-11D-A29J-05 eeda9161-2cf5-4ae2-b8ca-99bd13c053e4 eeda9161-2cf5-4ae2-b8ca-99bd13c053e4 TCGA-OR-A5K6-01A-11D-A29H-01 TCGA-OR-A5K6-01 TCGA-OR-A5K6-01 eeda9161-2cf5-4ae2-b8ca-99bd13c053e4 TCGA-OR-A5K6-01A-11D-A29H-01 TCGA-OR-A5K6-01A-11D-A29I-10 TCGA-OR-A5K6-01A-11D-A29I-10 +TCGA-OR-A5K8-01 TCGA-OR-A5K8-01 TCGA-OR-A5K8 TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 39 Atypical Mitotic Figures Absent TCGA-OR-A5K8-F59328 TCGA-OR-A5K8 TCGA-OR-A5K8-01A M0 Normal Cytoplasm presence <= 25% Absent -14435 260 0 749 Diffuse Architecture Present Both Clinical and Biochemical Assessments Cortisol 2014-5-8 MALE NO Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 590 Invasion of Tumor Capsule Present NO Right NO 7 YES YES NO Mitotic Rate > 5/50 HPF Present Necrosis Absent NO Nuclear Grade III or IV Present true No N0 T2 Stage II TCGA-OR-A5K8.1C0D3231-1F36-4645-95D2-C6BFF78734C9.pdf A5K8 TUMOR FREE No imaging evidence of disease YES NO Complete Remission/Response NO R0 Primary Tumor 01 Sinusoid Invasion Absent NO YES NO OR Adrenal A LIVING 4 Venous Invasion Absent 2012 TCGA-OR-A5K8-01A-11D-A29I-10 53390804-e59b-4e73-aee4-89daa7cde164 TCGA-OR-A5K8-01 TCGA-OR-A5K8-01 249586F7-DC75-489A-886E-3AECB9FA7B4B TCGA-OR-A5K8-01A-11D-A29J-05 53390804-e59b-4e73-aee4-89daa7cde164 53390804-e59b-4e73-aee4-89daa7cde164 TCGA-OR-A5K8-01A-11D-A29H-01 TCGA-OR-A5K8-01 TCGA-OR-A5K8-01 53390804-e59b-4e73-aee4-89daa7cde164 TCGA-OR-A5K8-01A-11D-A29H-01 TCGA-OR-A5K8-01A-11D-A29I-10 TCGA-OR-A5K8-01A-11D-A29I-10 +TCGA-OR-A5K9-01 TCGA-OR-A5K9-01 TCGA-OR-A5K9 TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 61 TCGA-OR-A5K9 TCGA-OR-A5K9-01A M0 -22596 3864 344 0 Both Clinical and Biochemical Assessments Androgen|Cortisol 2013-9-11 FEMALE Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 130 NO Right YES YES YES false No N0 T2 Stage II TCGA-OR-A5K9.EAC92541-2274-4FB8-B56B-657413EDF0F9.pdf A5K9 WITH TUMOR No imaging evidence of disease NO NO NO R0 Primary Tumor 01 NO YES OR Adrenal A DECEASED 2002 TCGA-OR-A5K9-01A-11D-A29I-10 48dd74fe-11ff-4514-87b3-1569e9606c73 TCGA-OR-A5K9-01 TCGA-OR-A5K9-01 TCGA-OR-A5K9-01A-11D-A29J-05 48dd74fe-11ff-4514-87b3-1569e9606c73 48dd74fe-11ff-4514-87b3-1569e9606c73 TCGA-OR-A5K9-01A-11D-A29H-01 TCGA-OR-A5K9-01 TCGA-OR-A5K9-01 48dd74fe-11ff-4514-87b3-1569e9606c73 TCGA-OR-A5K9-01A-11D-A29H-01 TCGA-OR-A5K9-01A-11D-A29I-10 TCGA-OR-A5K9-01A-11D-A29I-10 +TCGA-OR-A5KB-01 TCGA-OR-A5KB-01 TCGA-OR-A5KB TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland YES NO 61 Atypical Mitotic Figures Present TCGA-OR-A5KB-F59331 TCGA-OR-A5KB TCGA-OR-A5KB-01A M0 Normal Cytoplasm presence <= 25% Absent -22550 355 0 741 214 Diffuse Architecture Present None 2014-5-8 FEMALE NO YES Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 60 Invasion of Tumor Capsule Present NO Left NO 3 129 YES YES Mitotic Rate > 5/50 HPF Present Necrosis Present Pathology Soft Tissue Distant Metastasis NO YES Nuclear Grade III or IV Present 0 true No N0 T2 Stage II TCGA-OR-A5KB.7553DC0B-FD8C-42E9-B38F-65EA954C6BC6.pdf A5KB WITH TUMOR No imaging evidence of disease YES YES Progressive Disease NO R0 Primary Tumor 01 Sinusoid Invasion Absent YES NO YES OR Adrenal A LIVING 7 Venous Invasion Present 2011 TCGA-OR-A5KB-01A-11D-A30A-10 TCGA-OR-A5KB-01A-11D-A309-01 TCGA-OR-A5KB-01A-11D-A309-01 TCGA-OR-A5KB-01A-11D-A30A-10 TCGA-OR-A5KB-01A-11D-A30A-10 +TCGA-OR-A5KO-01 TCGA-OR-A5KO-01 TCGA-OR-A5KO TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland YES NO 39 Atypical Mitotic Figures Present TCGA-OR-A5KO-F60521 TCGA-OR-A5KO TCGA-OR-A5KO-01A M1 Liver Involvement Cytoplasm presence <= 25% Present -14606 1120 0 1414 561 541 Diffuse Architecture Present Both Clinical and Biochemical Assessments Cortisol 2014-6-10 FEMALE NO YES Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 80 Invasion of Tumor Capsule Present NO Right NO Biopsy Proven|Imaging Suspected YES YES Mitotic Rate > 5/50 HPF Present Necrosis Present Pathology Lung Distant Metastasis YES YES Nuclear Grade III or IV Present true No N0 T4 Stage IV TCGA-OR-A5KO.B9C848FD-453C-4A56-B625-C4C680790D6A.pdf A5KO WITH TUMOR No imaging evidence of disease YES Complete Remission/Response NO R0 Primary Tumor 01 Sinusoid Invasion Present NO NO YES OR Adrenal A LIVING 9 Venous Invasion Present 2009 TCGA-OR-A5KO-01A-11D-A29I-10 0ffc0b01-bc1c-4277-8fc4-865590dcc461 TCGA-OR-A5KO-01 TCGA-OR-A5KO-01 FFAC8C02-F5D7-4291-8A9A-EC07D7B0AAAC TCGA-OR-A5KO-01A-11D-A29J-05 0ffc0b01-bc1c-4277-8fc4-865590dcc461 0ffc0b01-bc1c-4277-8fc4-865590dcc461 TCGA-OR-A5KO-01A-11D-A29H-01 TCGA-OR-A5KO-01 TCGA-OR-A5KO-01 0ffc0b01-bc1c-4277-8fc4-865590dcc461 TCGA-OR-A5KO-01A-11D-A29H-01 TCGA-OR-A5KO-01A-11D-A29I-10 TCGA-OR-A5KO-01A-11D-A29I-10 +TCGA-OR-A5KP-01 TCGA-OR-A5KP-01 TCGA-OR-A5KP TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland NO NO 45 Atypical Mitotic Figures Absent TCGA-OR-A5KP-F60584 TCGA-OR-A5KP TCGA-OR-A5KP-01A M0 Normal Cytoplasm presence <= 25% Present -16702 2281 0 2777 1267 1250 Diffuse Architecture Present Both Clinical and Biochemical Assessments Androgen|Cortisol 2014-6-11 FEMALE NO YES Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 80 Invasion of Tumor Capsule Present NO Left NO 2 YES YES Mitotic Rate > 5/50 HPF Absent Necrosis Present Pathology Liver Distant Metastasis YES YES Nuclear Grade III or IV Absent 0 true Yes N0 T2 Stage II TCGA-OR-A5KP.C07E8EA7-A221-40F9-9D19-A59DE0E52200.pdf A5KP TUMOR FREE No imaging evidence of disease YES YES Complete Remission/Response NO R0 Primary Tumor 01 Sinusoid Invasion Present YES NO YES OR Adrenal A LIVING 6 Venous Invasion Present 2006 TCGA-OR-A5KP-01A-11D-A30A-10 TCGA-OR-A5KP-01A-11D-A309-01 TCGA-OR-A5KP-01A-11D-A309-01 TCGA-OR-A5KP-01A-11D-A30A-10 TCGA-OR-A5KP-01A-11D-A30A-10 +TCGA-OR-A5KQ-01 TCGA-OR-A5KQ-01 TCGA-OR-A5KQ TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 20 Atypical Mitotic Figures Absent TCGA-OR-A5KQ-F60587 TCGA-OR-A5KQ TCGA-OR-A5KQ-01A M0 Normal Cytoplasm presence <= 25% Present -7459 2490 0 2677 Diffuse Architecture Absent Both Clinical and Biochemical Assessments Androgen|Mineralocorticoids 2014-6-11 FEMALE NO Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 60 Invasion of Tumor Capsule Absent NO Right NO NO NO Mitotic Rate > 5/50 HPF Absent Necrosis Absent NO Nuclear Grade III or IV Present true No N0 T2 Stage II TCGA-OR-A5KQ.7ED6314A-1343-47D5-A40D-4B53FA3D33DF.pdf A5KQ TUMOR FREE No imaging evidence of disease NO Complete Remission/Response NO R0 Primary Tumor 01 Sinusoid Invasion Present NO YES OR Adrenal A LIVING 3 Venous Invasion Absent 2006 TCGA-OR-A5KQ-01A-11D-A30A-10 TCGA-OR-A5KQ-01A-11D-A309-01 TCGA-OR-A5KQ-01A-11D-A309-01 TCGA-OR-A5KQ-01A-11D-A30A-10 TCGA-OR-A5KQ-01A-11D-A30A-10 +TCGA-OR-A5KS-01 TCGA-OR-A5KS-01 TCGA-OR-A5KS TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 72 TCGA-OR-A5KS-F61319 TCGA-OR-A5KS TCGA-OR-A5KS-01A M0 Normal -26404 2425 0 2549 None 2014-6-26 MALE NO Adrenocortical carcinoma- Usual Type No C74.0 8370/1 C74.0 YES 120 NO Left NO 0 NO NO Necrosis Present NO true No N0 T2 Stage II TCGA-OR-A5KS.CF5CAAE7-CEA0-4505-A33F-7E7588DB7D7C.pdf A5KS TUMOR FREE No imaging evidence of disease NO NO Complete Remission/Response NO R0 Primary Tumor 01 NO YES OR Adrenal A LIVING 2006 TCGA-OR-A5KS-01A-11D-A30A-10 TCGA-OR-A5KS-01A-11D-A309-01 TCGA-OR-A5KS-01A-11D-A309-01 TCGA-OR-A5KS-01A-11D-A30A-10 TCGA-OR-A5KS-01A-11D-A30A-10 +TCGA-OR-A5KT-01 TCGA-OR-A5KT-01 TCGA-OR-A5KT TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland YES NO 44 Atypical Mitotic Figures Absent TCGA-OR-A5KT-F60526 TCGA-OR-A5KT TCGA-OR-A5KT-01A M0 Normal Cytoplasm presence <= 25% Present -16217 2399 0 2895 2112 2099 Diffuse Architecture Absent Both Clinical and Biochemical Assessments Androgen|Cortisol 2014-6-10 FEMALE NO YES Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 80 Invasion of Tumor Capsule Absent NO Left NO 1 NO NO Mitotic Rate > 5/50 HPF Absent Necrosis Present Pathology Other, specify Distant Metastasis Pancreas YES YES Nuclear Grade III or IV Absent true No N0 T1 Stage I TCGA-OR-A5KT.7BE65565-0C63-466C-AE5D-A9B47BB354C9.pdf A5KT TUMOR FREE No imaging evidence of disease NO Complete Remission/Response NO R0 Primary Tumor 01 Sinusoid Invasion Absent NO YES OR Adrenal A LIVING 2 Venous Invasion Absent 2006 TCGA-OR-A5KT-01A-11D-A29I-10 8448744c-2c5f-4a95-b517-5652f6bacc1a TCGA-OR-A5KT-01 TCGA-OR-A5KT-01 TCGA-OR-A5KT-01A-11D-A29J-05 8448744c-2c5f-4a95-b517-5652f6bacc1a 8448744c-2c5f-4a95-b517-5652f6bacc1a TCGA-OR-A5KT-01A-11D-A29H-01 TCGA-OR-A5KT-01 TCGA-OR-A5KT-01 8448744c-2c5f-4a95-b517-5652f6bacc1a TCGA-OR-A5KT-01A-11D-A29H-01 TCGA-OR-A5KT-01A-11D-A29I-10 TCGA-OR-A5KT-01A-11D-A29I-10 +TCGA-OR-A5KU-01 TCGA-OR-A5KU-01 TCGA-OR-A5KU TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 37 Atypical Mitotic Figures Absent TCGA-OR-A5KU-F60523 TCGA-OR-A5KU TCGA-OR-A5KU-01A M0 Normal Cytoplasm presence <= 25% Present -13559 4543 0 4673 Diffuse Architecture Absent Both Clinical and Biochemical Assessments Mineralocorticoids 2014-6-10 FEMALE NO Adrenocortical carcinoma- Usual Type No C74.0 8370/1 C74.0 YES 70 Invasion of Tumor Capsule Absent NO Left NO 1 YES YES Mitotic Rate > 5/50 HPF Absent Necrosis Present NO Nuclear Grade III or IV Absent 0 true No N0 T2 Stage II TCGA-OR-A5KU.F9F537ED-3066-4E99-B6D1-112D6C4551F0.pdf A5KU TUMOR FREE No imaging evidence of disease YES YES Complete Remission/Response NO R0 Primary Tumor 01 Sinusoid Invasion Absent NO NO NO YES OR Adrenal A LIVING 2 Venous Invasion Absent 2000 TCGA-OR-A5KU-01A-11D-A29I-10 c2e40ad2-0d7f-4e25-a93a-f9dba30bc838 TCGA-OR-A5KU-01 TCGA-OR-A5KU-01 49C334C1-C014-4BDD-817D-5BAF647C130C TCGA-OR-A5KU-01A-11D-A29J-05 c2e40ad2-0d7f-4e25-a93a-f9dba30bc838 c2e40ad2-0d7f-4e25-a93a-f9dba30bc838 TCGA-OR-A5KU-01A-11D-A29H-01 TCGA-OR-A5KU-01 TCGA-OR-A5KU-01 c2e40ad2-0d7f-4e25-a93a-f9dba30bc838 TCGA-OR-A5KU-01A-11D-A29H-01 TCGA-OR-A5KU-01A-11D-A29I-10 TCGA-OR-A5KU-01A-11D-A29I-10 +TCGA-OR-A5KV-01 TCGA-OR-A5KV-01 TCGA-OR-A5KV TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland NO NO 17 Atypical Mitotic Figures Present TCGA-OR-A5KV-F60525 TCGA-OR-A5KV TCGA-OR-A5KV-01A M0 Retroperitoneal Lymph Node Involvement Cytoplasm presence <= 25% Absent -6250 3429 0 3878 1120 1116 Diffuse Architecture Absent Biochemical Assessment Androgen|Cortisol 2014-6-10 FEMALE NO YES Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 50 Invasion of Tumor Capsule Absent NO Left NO 1 NO NO Mitotic Rate > 5/50 HPF Absent Necrosis Present Imaging Lung Distant Metastasis YES YES Nuclear Grade III or IV Present 1 true No N1 T2 Stage III TCGA-OR-A5KV.D85CC5BA-0A85-4BCB-8088-9EBA37211501.pdf A5KV TUMOR FREE No imaging evidence of disease NO YES Complete Remission/Response YES R0 Primary Tumor 01 Sinusoid Invasion Absent NO YES OR Adrenal A LIVING 3 Venous Invasion Absent 2003 TCGA-OR-A5KV-01A-11D-A29I-10 512b54a3-49c4-4dbd-b853-290500c00e81 TCGA-OR-A5KV-01 TCGA-OR-A5KV-01 TCGA-OR-A5KV-01A-11D-A29J-05 512b54a3-49c4-4dbd-b853-290500c00e81 512b54a3-49c4-4dbd-b853-290500c00e81 TCGA-OR-A5KV-01A-11D-A29H-01 TCGA-OR-A5KV-01 TCGA-OR-A5KV-01 512b54a3-49c4-4dbd-b853-290500c00e81 TCGA-OR-A5KV-01A-11D-A29H-01 TCGA-OR-A5KV-01A-11D-A29I-10 TCGA-OR-A5KV-01A-11D-A29I-10 +TCGA-OR-A5KW-01 TCGA-OR-A5KW-01 TCGA-OR-A5KW TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 55 TCGA-OR-A5KW-F60532 TCGA-OR-A5KW TCGA-OR-A5KW-01A M0 Retroperitoneal Lymph Node Involvement -20328 1245 0 2076 Both Clinical and Biochemical Assessments Androgen|Cortisol 2014-6-10 FEMALE NO Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 230 NO Right NO 9 10 YES YES NO 8 true No N1 T2 Stage III TCGA-OR-A5KW.751F5B53-9186-4602-B824-8593E63EAC3F.pdf A5KW TUMOR FREE No imaging evidence of disease YES YES Complete Remission/Response YES R0 Primary Tumor 01 YES NO NO YES OR Adrenal A LIVING 2009 TCGA-OR-A5KW-01A-11D-A29I-10 64934de4-399f-4fbc-b283-979ab40addbc TCGA-OR-A5KW-01 TCGA-OR-A5KW-01 767EAE99-8013-4CC9-ACA6-DCA18CD8A8D0 TCGA-OR-A5KW-01A-11D-A29J-05 64934de4-399f-4fbc-b283-979ab40addbc 64934de4-399f-4fbc-b283-979ab40addbc TCGA-OR-A5KW-01A-11D-A29H-01 TCGA-OR-A5KW-01 TCGA-OR-A5KW-01 64934de4-399f-4fbc-b283-979ab40addbc TCGA-OR-A5KW-01A-11D-A29H-01 TCGA-OR-A5KW-01A-11D-A29I-10 TCGA-OR-A5KW-01A-11D-A29I-10 +TCGA-OR-A5KX-01 TCGA-OR-A5KX-01 TCGA-OR-A5KX TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland YES YES 25 Atypical Mitotic Figures Absent TCGA-OR-A5KX-F60522 TCGA-OR-A5KX TCGA-OR-A5KX-01A M0 Normal Cytoplasm presence <= 25% Present -9298 914 0 1364 69 62 Diffuse Architecture Present 2014-6-10 FEMALE NO YES Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 190 Invasion of Tumor Capsule Present NO Left NO YES YES Mitotic Rate > 5/50 HPF Present Necrosis Present Pathology Bone Distant Metastasis YES YES Nuclear Grade III or IV Present true No N1 T2 Stage III TCGA-OR-A5KX.02EBE0C2-AE20-4F08-81E7-3EC45E12C0F4.pdf A5KX WITH TUMOR Persistent distant metastases YES YES Progressive Disease NO R0 Primary Tumor 01 Sinusoid Invasion Absent YES NO YES OR Adrenal A LIVING 7 Venous Invasion Present 2010 TCGA-OR-A5KX-01A-11D-A29I-10 180a84c1-99c0-4014-b42e-8e01f88980aa TCGA-OR-A5KX-01 TCGA-OR-A5KX-01 C9B17637-359A-485E-9CA4-0E92B840CD03 TCGA-OR-A5KX-01A-11D-A29J-05 180a84c1-99c0-4014-b42e-8e01f88980aa 180a84c1-99c0-4014-b42e-8e01f88980aa TCGA-OR-A5KX-01A-11D-A29H-01 TCGA-OR-A5KX-01 TCGA-OR-A5KX-01 180a84c1-99c0-4014-b42e-8e01f88980aa TCGA-OR-A5KX-01A-11D-A29H-01 TCGA-OR-A5KX-01A-11D-A29I-10 TCGA-OR-A5KX-01A-11D-A29I-10 +TCGA-OR-A5KY-01 TCGA-OR-A5KY-01 TCGA-OR-A5KY TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 23 Atypical Mitotic Figures Present TCGA-OR-A5KY TCGA-OR-A5KY-01A M1 Lung Involvement Cytoplasm presence <= 25% Present -8745 939 391 0 Diffuse Architecture Absent Both Clinical and Biochemical Assessments Androgen|Cortisol 2013-11-5 FEMALE NO Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 120 Invasion of Tumor Capsule Present NO Left 52 Imaging Suspected 5 YES NO YES Mitotic Rate > 5/50 HPF Absent Necrosis Absent YES Nuclear Grade III or IV Absent 52 true No N1 T4 Stage IV TCGA-OR-A5KY.23328F06-11F8-4D12-BA95-D5CC9AEFE22A.pdf A5KY WITH TUMOR Persistent distant metastases YES YES Progressive Disease NO R2 Primary Tumor 01 Sinusoid Invasion Absent YES NO NO YES OR Adrenal A DECEASED 3 Venous Invasion Absent 2010 TCGA-OR-A5KY-01A-11D-A29I-10 bf4dc301-6b99-46c3-bdc4-d85905688e05 TCGA-OR-A5KY-01 TCGA-OR-A5KY-01 75604E70-38A0-424C-97A9-4A1BA8F854CC TCGA-OR-A5KY-01A-11D-A29J-05 bf4dc301-6b99-46c3-bdc4-d85905688e05 bf4dc301-6b99-46c3-bdc4-d85905688e05 TCGA-OR-A5KY-01A-11D-A29H-01 TCGA-OR-A5KY-01 TCGA-OR-A5KY-01 bf4dc301-6b99-46c3-bdc4-d85905688e05 TCGA-OR-A5KY-01A-11D-A29H-01 TCGA-OR-A5KY-01A-11D-A29I-10 TCGA-OR-A5KY-01A-11D-A29I-10 +TCGA-OR-A5KZ-01 TCGA-OR-A5KZ-01 TCGA-OR-A5KZ TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 42 Atypical Mitotic Figures Absent TCGA-OR-A5KZ TCGA-OR-A5KZ-01A M0 Normal Cytoplasm presence <= 25% Present -15594 319 125 0 Diffuse Architecture Present Both Clinical and Biochemical Assessments Cortisol 2013-11-7 MALE NO Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 120 Invasion of Tumor Capsule Present NO Left YES YES Mitotic Rate > 5/50 HPF Present Necrosis Present YES Nuclear Grade III or IV Present true No N0 T2 Stage II TCGA-OR-A5KZ.22298C81-A72D-4E22-99DD-6541FB0953A4.pdf A5KZ WITH TUMOR Persistent locoregional disease YES Progressive Disease NO RX Primary Tumor 01 Sinusoid Invasion Present NO YES OR Adrenal A DECEASED 8 Venous Invasion Present 2012 TCGA-OR-A5KZ-01A-11D-A29I-10 6991a561-ff49-4546-9bc7-74cca88916ae TCGA-OR-A5KZ-01 TCGA-OR-A5KZ-01 5D348448-A293-4A3F-81F2-94BDD97B882D TCGA-OR-A5KZ-01A-11D-A29J-05 6991a561-ff49-4546-9bc7-74cca88916ae 6991a561-ff49-4546-9bc7-74cca88916ae TCGA-OR-A5KZ-01A-11D-A29H-01 TCGA-OR-A5KZ-01 TCGA-OR-A5KZ-01 6991a561-ff49-4546-9bc7-74cca88916ae TCGA-OR-A5KZ-01A-11D-A29H-01 TCGA-OR-A5KZ-01A-11D-A29I-10 TCGA-OR-A5KZ-01A-11D-A29I-10 +TCGA-OR-A5L1-01 TCGA-OR-A5L1-01 TCGA-OR-A5L1 TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 37 TCGA-OR-A5L1 TCGA-OR-A5L1-01A M0 Normal -13840 4424 0 1781 Biochemical Assessment Cortisol 2014-6-27 FEMALE NO Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 160 NO Left YES YES Necrosis Present YES true No N0 T2 Stage II TCGA-OR-A5L1.914A8783-5ACF-4580-A663-E73BDDAA7286.pdf A5L1 WITH TUMOR YES NO Complete Remission/Response NO R0 Primary Tumor 01 NO YES OR Adrenal A LIVING 2000 TCGA-OR-A5L1-01A-11D-A30A-10 TCGA-OR-A5L1-01A-11D-A309-01 TCGA-OR-A5L1-01A-11D-A309-01 TCGA-OR-A5L1-01A-11D-A30A-10 TCGA-OR-A5L1-01A-11D-A30A-10 +TCGA-OR-A5L2-01 TCGA-OR-A5L2-01 TCGA-OR-A5L2 TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 83 Atypical Mitotic Figures Present TCGA-OR-A5L2-F61320 TCGA-OR-A5L2 TCGA-OR-A5L2-01A M0 Normal -30535 4313 1852 0 2014-6-26 FEMALE NO Adrenocortical carcinoma- Usual Type No C74.0 8370/1 C74.0 YES 110 Invasion of Tumor Capsule Absent NO Left NO 30 NO NO Mitotic Rate > 5/50 HPF Present Necrosis Present NO true No N0 T2 Stage II TCGA-OR-A5L2.A3E8E475-D5A7-4A4C-AA1D-3B3AE50F572B.pdf A5L2 TUMOR FREE No imaging evidence of disease NO NO Complete Remission/Response NO R0 Primary Tumor 01 NO YES OR Adrenal A DECEASED 2001 TCGA-OR-A5L2-01A-11D-A30A-10 TCGA-OR-A5L2-01A-11D-A309-01 TCGA-OR-A5L2-01A-11D-A309-01 TCGA-OR-A5L2-01A-11D-A30A-10 TCGA-OR-A5L2-01A-11D-A30A-10 +TCGA-OR-A5L3-01 TCGA-OR-A5L3-01 TCGA-OR-A5L3 TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 67 Atypical Mitotic Figures Absent TCGA-OR-A5L3-F60524 TCGA-OR-A5L3 TCGA-OR-A5L3-01A M0 Normal Cytoplasm presence <= 25% Absent -24763 4591 0 4628 Diffuse Architecture Absent Both Clinical and Biochemical Assessments Cortisol 2014-6-10 FEMALE NO Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 70 Invasion of Tumor Capsule Absent NO Right NO NO NO Mitotic Rate > 5/50 HPF Absent Necrosis Present NO Nuclear Grade III or IV Present true No N0 T1 Stage I TCGA-OR-A5L3.FE1CF238-753C-4DF4-A083-74DDC753DF45.pdf A5L3 TUMOR FREE No imaging evidence of disease NO Complete Remission/Response NO R0 Primary Tumor 01 Sinusoid Invasion Present NO YES OR Adrenal A LIVING 3 Venous Invasion Absent 2000 TCGA-OR-A5L3-01A-11D-A29I-10 20f7acf8-7813-4ec8-af92-19f92d875a58 TCGA-OR-A5L3-01 TCGA-OR-A5L3-01 TCGA-OR-A5L3-01A-11D-A29J-05 20f7acf8-7813-4ec8-af92-19f92d875a58 20f7acf8-7813-4ec8-af92-19f92d875a58 TCGA-OR-A5L3-01A-11D-A29H-01 TCGA-OR-A5L3-01 TCGA-OR-A5L3-01 20f7acf8-7813-4ec8-af92-19f92d875a58 TCGA-OR-A5L3-01A-11D-A29H-01 TCGA-OR-A5L3-01A-11D-A29I-10 TCGA-OR-A5L3-01A-11D-A29I-10 +TCGA-OR-A5L4-01 TCGA-OR-A5L4-01 TCGA-OR-A5L4 TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 48 Atypical Mitotic Figures Absent TCGA-OR-A5L4-F60529 TCGA-OR-A5L4 TCGA-OR-A5L4-01A M0 Normal Cytoplasm presence <= 25% Present -17819 456 0 967 Diffuse Architecture Present Both Clinical and Biochemical Assessments Androgen|Cortisol 2014-6-10 FEMALE NO Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 80 Invasion of Tumor Capsule Present NO Right NO YES YES Mitotic Rate > 5/50 HPF Absent Necrosis Present NO Nuclear Grade III or IV Present true No N0 T4 Stage III TCGA-OR-A5L4.B140F5B4-5B03-40EC-A5BB-BCF0963EC567.pdf A5L4 TUMOR FREE No imaging evidence of disease YES Complete Remission/Response NO RX Primary Tumor 01 Sinusoid Invasion Present YES NO NO YES OR Adrenal A LIVING 7 Venous Invasion Present 2011 TCGA-OR-A5L4-01A-11D-A29I-10 67affce9-7c50-46c9-9f1c-f80c1dd9c888 TCGA-OR-A5L4-01 TCGA-OR-A5L4-01 TCGA-OR-A5L4-01A-11D-A29J-05 67affce9-7c50-46c9-9f1c-f80c1dd9c888 67affce9-7c50-46c9-9f1c-f80c1dd9c888 TCGA-OR-A5L4-01A-11D-A29H-01 TCGA-OR-A5L4-01 TCGA-OR-A5L4-01 67affce9-7c50-46c9-9f1c-f80c1dd9c888 TCGA-OR-A5L4-01A-11D-A29H-01 TCGA-OR-A5L4-01A-11D-A29I-10 TCGA-OR-A5L4-01A-11D-A29I-10 +TCGA-OR-A5L5-01 TCGA-OR-A5L5-01 TCGA-OR-A5L5 TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 77 Atypical Mitotic Figures Absent TCGA-OR-A5L5-F60530 TCGA-OR-A5L5 TCGA-OR-A5L5-01A M0 Normal Cytoplasm presence <= 25% Absent -28270 828 0 1317 Diffuse Architecture Absent Biochemical Assessment Androgen|Estrogen 2014-6-10 FEMALE NO Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 70 Invasion of Tumor Capsule Present NO Left NO 15 NO NO Mitotic Rate > 5/50 HPF Present Necrosis Present NO Nuclear Grade III or IV Present true Yes N0 T1 Stage I TCGA-OR-A5L5.A1989B2E-FB1F-420A-BF11-2C79F3E81884.pdf A5L5 TUMOR FREE No imaging evidence of disease YES NO Complete Remission/Response NO R0 Primary Tumor 01 NO YES OR Adrenal A LIVING 4 2010 TCGA-OR-A5L5-01A-11D-A29I-10 2928fe95-b646-44a3-808a-36f0751c887b TCGA-OR-A5L5-01 TCGA-OR-A5L5-01 TCGA-OR-A5L5-01A-11D-A29J-05 2928fe95-b646-44a3-808a-36f0751c887b 2928fe95-b646-44a3-808a-36f0751c887b TCGA-OR-A5L5-01A-11D-A29H-01 TCGA-OR-A5L5-01 TCGA-OR-A5L5-01 2928fe95-b646-44a3-808a-36f0751c887b TCGA-OR-A5L5-01A-11D-A29H-01 TCGA-OR-A5L5-01A-11D-A29I-10 TCGA-OR-A5L5-01A-11D-A29I-10 +TCGA-OR-A5L6-01 TCGA-OR-A5L6-01 TCGA-OR-A5L6 TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 60 Atypical Mitotic Figures Absent TCGA-OR-A5L6-F60528 TCGA-OR-A5L6 TCGA-OR-A5L6-01A M0 Normal Cytoplasm presence <= 25% Present -22057 433 0 861 Diffuse Architecture Present Biochemical Assessment Androgen 2014-6-10 MALE NO Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 80 Invasion of Tumor Capsule Absent NO Left NO 23 NO NO Mitotic Rate > 5/50 HPF Present Necrosis Present NO Nuclear Grade III or IV Present true No N0 T2 Stage II TCGA-OR-A5L6.6104CA0C-86CD-46C9-A111-0024A75FB727.pdf A5L6 TUMOR FREE No imaging evidence of disease NO Complete Remission/Response NO R0 Primary Tumor 01 Sinusoid Invasion Present NO YES OR Adrenal A LIVING 7 Venous Invasion Present 2011 TCGA-OR-A5L6-01A-11D-A29I-10 68206c96-7d72-43e9-92c8-75f6b5a3f14c TCGA-OR-A5L6-01 TCGA-OR-A5L6-01 TCGA-OR-A5L6-01A-11D-A29J-05 68206c96-7d72-43e9-92c8-75f6b5a3f14c 68206c96-7d72-43e9-92c8-75f6b5a3f14c TCGA-OR-A5L6-01A-11D-A29H-01 TCGA-OR-A5L6-01 TCGA-OR-A5L6-01 68206c96-7d72-43e9-92c8-75f6b5a3f14c TCGA-OR-A5L6-01A-11D-A29H-01 TCGA-OR-A5L6-01A-11D-A29I-10 TCGA-OR-A5L6-01A-11D-A29I-10 +TCGA-OR-A5L8-01 TCGA-OR-A5L8-01 TCGA-OR-A5L8 TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 36 Atypical Mitotic Figures Absent TCGA-OR-A5L8-F60527 TCGA-OR-A5L8 TCGA-OR-A5L8-01A M0 Normal Cytoplasm presence <= 25% Present -13472 558 0 885 Diffuse Architecture Absent Both Clinical and Biochemical Assessments Mineralocorticoids|Cortisol 2014-6-10 FEMALE NO Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 70 Invasion of Tumor Capsule Present NO Right NO YES YES Mitotic Rate > 5/50 HPF Absent Necrosis Absent NO Nuclear Grade III or IV Absent true No N0 T2 Stage II TCGA-OR-A5L8.C4BBFD0B-83D0-47C8-9662-13691FE6D820.pdf A5L8 TUMOR FREE No imaging evidence of disease YES NO Complete Remission/Response NO R0 Primary Tumor 01 Sinusoid Invasion Present YES NO NO YES OR Adrenal A LIVING 4 Venous Invasion Present 2011 TCGA-OR-A5L8-01A-11D-A29I-10 3fd3dae2-aeeb-4d42-abcd-7ff49079e909 TCGA-OR-A5L8-01 TCGA-OR-A5L8-01 TCGA-OR-A5L8-01A-11D-A29J-05 3fd3dae2-aeeb-4d42-abcd-7ff49079e909 3fd3dae2-aeeb-4d42-abcd-7ff49079e909 TCGA-OR-A5L8-01A-11D-A29H-01 TCGA-OR-A5L8-01 TCGA-OR-A5L8-01 3fd3dae2-aeeb-4d42-abcd-7ff49079e909 TCGA-OR-A5L8-01A-11D-A29H-01 TCGA-OR-A5L8-01A-11D-A29I-10 TCGA-OR-A5L8-01A-11D-A29I-10 +TCGA-OR-A5L9-01 TCGA-OR-A5L9-01 TCGA-OR-A5L9 TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 53 Atypical Mitotic Figures Absent TCGA-OR-A5L9-F61321 TCGA-OR-A5L9 M0 Normal Cytoplasm presence <= 25% Present -19526 0 871 Diffuse Architecture Absent Both Clinical and Biochemical Assessments Androgen 2014-6-26 FEMALE NO Adrenocortical carcinoma- Usual Type No C74.0 8370/1 C74.0 YES Invasion of Tumor Capsule Absent Right NO 5 5 YES YES Mitotic Rate > 5/50 HPF Absent Necrosis Present NO Nuclear Grade III or IV Present 0 No N0 T2 Stage II A5L9 TUMOR FREE No imaging evidence of disease YES YES Complete Remission/Response NO R0 Primary Tumor 01 Sinusoid Invasion Absent YES NO NO YES OR Adrenal LIVING 3 Venous Invasion Absent 2011 TCGA-OR-A5L9-01A-11D-A29I-10 cfa39c30-f619-4cf8-8460-31d5e5a3b3ba TCGA-OR-A5L9-01 TCGA-OR-A5L9-01 TCGA-OR-A5L9-01A-11D-A29J-05 cfa39c30-f619-4cf8-8460-31d5e5a3b3ba cfa39c30-f619-4cf8-8460-31d5e5a3b3ba TCGA-OR-A5L9-01A-11D-A29H-01 TCGA-OR-A5L9-01 TCGA-OR-A5L9-01 cfa39c30-f619-4cf8-8460-31d5e5a3b3ba TCGA-OR-A5L9-01A-11D-A29H-01 TCGA-OR-A5L9-01A-11D-A29I-10 TCGA-OR-A5L9-01A-11D-A29I-10 +TCGA-OR-A5LA-01 TCGA-OR-A5LA-01 TCGA-OR-A5LA TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 52 Atypical Mitotic Figures Absent TCGA-OR-A5LA-F60533 TCGA-OR-A5LA TCGA-OR-A5LA-01A M0 Normal Cytoplasm presence <= 25% Present -19242 208 0 719 Diffuse Architecture Present None 2014-6-10 FEMALE NO Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 60 Invasion of Tumor Capsule Present NO Left NO 1 YES YES Mitotic Rate > 5/50 HPF Absent Necrosis Present NO Nuclear Grade III or IV Present true No N0 T2 Stage II TCGA-OR-A5LA.68F5B84D-8967-4A77-B5D9-65526AB9FFBB.pdf A5LA TUMOR FREE No imaging evidence of disease YES NO Complete Remission/Response NO R0 Primary Tumor 01 Sinusoid Invasion Absent YES NO NO YES OR Adrenal A LIVING 5 Venous Invasion Absent 2012 TCGA-OR-A5LA-01A-11D-A29I-10 8e63ada3-97ca-46ab-984d-6a71a4e4e440 TCGA-OR-A5LA-01 TCGA-OR-A5LA-01 TCGA-OR-A5LA-01A-11D-A29J-05 8e63ada3-97ca-46ab-984d-6a71a4e4e440 8e63ada3-97ca-46ab-984d-6a71a4e4e440 TCGA-OR-A5LA-01A-11D-A29H-01 TCGA-OR-A5LA-01 TCGA-OR-A5LA-01 8e63ada3-97ca-46ab-984d-6a71a4e4e440 TCGA-OR-A5LA-01A-11D-A29H-01 TCGA-OR-A5LA-01A-11D-A29I-10 TCGA-OR-A5LA-01A-11D-A29I-10 +TCGA-OR-A5LB-01 TCGA-OR-A5LB-01 TCGA-OR-A5LB TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 59 Atypical Mitotic Figures Absent TCGA-OR-A5LB TCGA-OR-A5LB-01A M1 Lung Involvement Cytoplasm presence <= 25% Absent -21565 2386 1204 0 Diffuse Architecture Present Vena cava and left atrium of the heart Biochemical Assessment Androgen 2013-11-4 MALE NO Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 40 Invasion of Tumor Capsule Absent NO Right Other, specify Operation 8 YES YES Mitotic Rate > 5/50 HPF Present Necrosis Absent YES Nuclear Grade III or IV Absent true Yes N0 T4 Stage IV TCGA-OR-A5LB.09038444-9BE4-443C-8FEC-07903972F305.pdf A5LB WITH TUMOR No imaging evidence of disease YES NO Progressive Disease YES R0 Primary Tumor 01 Sinusoid Invasion Present YES YES NO YES OR Adrenal A DECEASED 4 Venous Invasion Present 2006 TCGA-OR-A5LB-01A-11D-A29I-10 881f6b71-7088-42c8-bfec-c86943715b56 TCGA-OR-A5LB-01 TCGA-OR-A5LB-01 TCGA-OR-A5LB-01A-11D-A29J-05 881f6b71-7088-42c8-bfec-c86943715b56 881f6b71-7088-42c8-bfec-c86943715b56 TCGA-OR-A5LB-01A-11D-A29H-01 TCGA-OR-A5LB-01 TCGA-OR-A5LB-01 881f6b71-7088-42c8-bfec-c86943715b56 TCGA-OR-A5LB-01A-11D-A29H-01 TCGA-OR-A5LB-01A-11D-A29I-10 TCGA-OR-A5LB-01A-11D-A29I-10 +TCGA-OR-A5LC-01 TCGA-OR-A5LC-01 TCGA-OR-A5LC TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 71 Atypical Mitotic Figures Absent TCGA-OR-A5LC M1 Liver Involvement Cytoplasm presence <= 25% Absent -26084 159 0 Diffuse Architecture Absent Both Clinical and Biochemical Assessments Cortisol 2013-11-4 FEMALE NO Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES Invasion of Tumor Capsule Present Left Biopsy Proven|Imaging Suspected YES YES Mitotic Rate > 5/50 HPF Absent Necrosis Present YES Nuclear Grade III or IV Absent No N0 T4 Stage IV A5LC WITH TUMOR Persistent distant metastases YES Progressive Disease NO R2 Primary Tumor 01 Sinusoid Invasion Absent NO NO YES OR Adrenal DECEASED 3 Venous Invasion Present 2011 TCGA-OR-A5LC-01A-11D-A29I-10 cbe8e9e4-f555-47ce-9905-d9f95637c18a TCGA-OR-A5LC-01 TCGA-OR-A5LC-01 TCGA-OR-A5LC-01A-11D-A29J-05 cbe8e9e4-f555-47ce-9905-d9f95637c18a cbe8e9e4-f555-47ce-9905-d9f95637c18a TCGA-OR-A5LC-01A-11D-A29H-01 TCGA-OR-A5LC-01 TCGA-OR-A5LC-01 cbe8e9e4-f555-47ce-9905-d9f95637c18a TCGA-OR-A5LC-01A-11D-A29H-01 TCGA-OR-A5LC-01A-11D-A29I-10 TCGA-OR-A5LC-01A-11D-A29I-10 +TCGA-OR-A5LD-01 TCGA-OR-A5LD-01 TCGA-OR-A5LD TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 52 Atypical Mitotic Figures Absent TCGA-OR-A5LD TCGA-OR-A5LD-01A M0 Normal Cytoplasm presence <= 25% Present -19111 5280 1197 0 Diffuse Architecture Present None 2013-11-7 MALE NO Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 200 Invasion of Tumor Capsule Absent NO Left NO Mitotic Rate > 5/50 HPF Present Necrosis Present YES Nuclear Grade III or IV Absent true No N0 T4 Stage III TCGA-OR-A5LD.08D3F046-01AD-40B2-A4EC-1121366614CA.pdf A5LD WITH TUMOR No imaging evidence of disease NO NO NO RX Primary Tumor 01 Sinusoid Invasion Present NO YES OR Adrenal A DECEASED 5 Venous Invasion Absent 1998 TCGA-OR-A5LD-01A-11D-A29I-10 efd6520f-20a3-416b-87ce-6a1da0da448d TCGA-OR-A5LD-01 TCGA-OR-A5LD-01 0AC0BCF3-1EC0-4DBB-A86D-3953B2F28AE8 TCGA-OR-A5LD-01A-11D-A29J-05 efd6520f-20a3-416b-87ce-6a1da0da448d efd6520f-20a3-416b-87ce-6a1da0da448d TCGA-OR-A5LD-01A-11D-A29H-01 TCGA-OR-A5LD-01 TCGA-OR-A5LD-01 efd6520f-20a3-416b-87ce-6a1da0da448d TCGA-OR-A5LD-01A-11D-A29H-01 TCGA-OR-A5LD-01A-11D-A29I-10 TCGA-OR-A5LD-01A-11D-A29I-10 +TCGA-OR-A5LE-01 TCGA-OR-A5LE-01 TCGA-OR-A5LE TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 14 Atypical Mitotic Figures Absent TCGA-OR-A5LE M0 Normal Cytoplasm presence <= 25% Present -5383 662 0 Diffuse Architecture Absent 2013-11-4 MALE NO Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES Invasion of Tumor Capsule Absent Left NO Mitotic Rate > 5/50 HPF Present Necrosis Present YES Nuclear Grade III or IV Present No N0 T2 Stage II A5LE WITH TUMOR No imaging evidence of disease NO YES NO R0 Primary Tumor 01 Sinusoid Invasion Present NO YES OR Adrenal DECEASED 5 Venous Invasion Absent 1997 TCGA-OR-A5LE-01A-11D-A29I-10 d5597a19-f3ff-431b-85ba-d2f306fe2fab TCGA-OR-A5LE-01 TCGA-OR-A5LE-01 TCGA-OR-A5LE-01A-11D-A29J-05 d5597a19-f3ff-431b-85ba-d2f306fe2fab d5597a19-f3ff-431b-85ba-d2f306fe2fab TCGA-OR-A5LE-01A-11D-A29H-01 TCGA-OR-A5LE-01 TCGA-OR-A5LE-01 d5597a19-f3ff-431b-85ba-d2f306fe2fab TCGA-OR-A5LE-01A-11D-A29H-01 TCGA-OR-A5LE-01A-11D-A29I-10 TCGA-OR-A5LE-01A-11D-A29I-10 +TCGA-OR-A5LF-01 TCGA-OR-A5LF-01 TCGA-OR-A5LF TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 74 Atypical Mitotic Figures Absent TCGA-OR-A5LF TCGA-OR-A5LF-01A M0 Normal Cytoplasm presence <= 25% Present -27179 3880 445 0 Diffuse Architecture Present None 2014-6-27 FEMALE NO Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 110 Invasion of Tumor Capsule Present NO Left NO Mitotic Rate > 5/50 HPF Present Necrosis Absent NO Nuclear Grade III or IV Absent true No N0 T3 Stage III TCGA-OR-A5LF.1E988E48-9FF4-4355-89CE-410CC1964D6C.pdf A5LF TUMOR FREE No imaging evidence of disease NO NO Complete Remission/Response NO R0 Primary Tumor 01 Sinusoid Invasion Absent NO YES OR Adrenal A DECEASED 5 Venous Invasion Present 2002 TCGA-OR-A5LF-01A-11D-A30A-10 TCGA-OR-A5LF-01A-11D-A309-01 TCGA-OR-A5LF-01A-11D-A309-01 TCGA-OR-A5LF-01A-11D-A30A-10 TCGA-OR-A5LF-01A-11D-A30A-10 +TCGA-OR-A5LG-01 TCGA-OR-A5LG-01 TCGA-OR-A5LG TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 46 Atypical Mitotic Figures Present TCGA-OR-A5LG TCGA-OR-A5LG-01A M0 Normal Cytoplasm presence <= 25% Present -16875 1667 0 1589 Diffuse Architecture Present Both Clinical and Biochemical Assessments Cortisol 2013-11-5 MALE NO Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 180 Invasion of Tumor Capsule Present NO Left 1 YES YES Mitotic Rate > 5/50 HPF Present Necrosis Absent YES Nuclear Grade III or IV Present 0 true No N0 T3 Stage III TCGA-OR-A5LG.DA704AB1-8D08-48EC-9F62-A6B5E69E4DC7.pdf A5LG WITH TUMOR No imaging evidence of disease YES YES Complete Remission/Response NO RX Primary Tumor 01 Sinusoid Invasion Absent YES NO NO YES OR Adrenal A LIVING 6 Venous Invasion Absent 2008 TCGA-OR-A5LG-01A-11D-A29I-10 bdacf802-7670-445e-a1bc-1833c833940e TCGA-OR-A5LG-01 TCGA-OR-A5LG-01 3C264BFC-0334-4FE8-8523-279090AF04AA TCGA-OR-A5LG-01A-11D-A29J-05 bdacf802-7670-445e-a1bc-1833c833940e bdacf802-7670-445e-a1bc-1833c833940e TCGA-OR-A5LG-01A-11D-A29H-01 TCGA-OR-A5LG-01 TCGA-OR-A5LG-01 bdacf802-7670-445e-a1bc-1833c833940e TCGA-OR-A5LG-01A-11D-A29H-01 TCGA-OR-A5LG-01A-11D-A29I-10 TCGA-OR-A5LG-01A-11D-A29I-10 +TCGA-OR-A5LH-01 TCGA-OR-A5LH-01 TCGA-OR-A5LH TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 36 Atypical Mitotic Figures Present TCGA-OR-A5LH TCGA-OR-A5LH-01A M0 Normal Cytoplasm presence <= 25% Absent -13182 2731 2385 0 Diffuse Architecture Absent Both Clinical and Biochemical Assessments Androgen 2013-11-5 FEMALE NO Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 130 Invasion of Tumor Capsule Absent NO Left 5 YES YES Mitotic Rate > 5/50 HPF Absent Necrosis Present NO Nuclear Grade III or IV Absent true No N0 T2 Stage II TCGA-OR-A5LH.093D8D72-8D1B-4C23-A132-D0DCBB05DE26.pdf A5LH WITH TUMOR Persistent distant metastases YES NO Progressive Disease NO R0 Primary Tumor 01 Sinusoid Invasion Present NO YES OR Adrenal A DECEASED 3 Venous Invasion Absent 2005 TCGA-OR-A5LH-01A-11D-A29I-10 44c5a1b9-e7e0-41ae-85e2-d1f05915ce3c TCGA-OR-A5LH-01 TCGA-OR-A5LH-01 6BB4B44E-2E16-41BA-8811-66740A96C3F3 TCGA-OR-A5LH-01A-11D-A29J-05 44c5a1b9-e7e0-41ae-85e2-d1f05915ce3c 44c5a1b9-e7e0-41ae-85e2-d1f05915ce3c TCGA-OR-A5LH-01A-11D-A29H-01 TCGA-OR-A5LH-01 TCGA-OR-A5LH-01 44c5a1b9-e7e0-41ae-85e2-d1f05915ce3c TCGA-OR-A5LH-01A-11D-A29H-01 TCGA-OR-A5LH-01A-11D-A29I-10 TCGA-OR-A5LH-01A-11D-A29I-10 +TCGA-OR-A5LI-01 TCGA-OR-A5LI-01 TCGA-OR-A5LI TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland YES YES 42 Atypical Mitotic Figures Absent TCGA-OR-A5LI-F61316 TCGA-OR-A5LI TCGA-OR-A5LI-01A M1 Lung Involvement Cytoplasm presence <= 25% Present -15536 5353 436 0 61 Diffuse Architecture Present Both Clinical and Biochemical Assessments Androgen|Cortisol 2014-6-27 FEMALE NO NO Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 110 Invasion of Tumor Capsule Absent NO Right NO Imaging Suspected NO NO Mitotic Rate > 5/50 HPF Present Necrosis Present Imaging Bone Distant Metastasis NO YES Nuclear Grade III or IV Present true No N0 T4 Stage IV TCGA-OR-A5LI.087A53B3-572F-4492-8D19-7CFE41C8DA39.pdf A5LI WITH TUMOR Persistent distant metastases NO NO Progressive Disease NO R2 Primary Tumor 01 Sinusoid Invasion Present NO YES OR Adrenal A DECEASED 6 Venous Invasion Absent 1998 TCGA-OR-A5LI-01A-11D-A30A-10 TCGA-OR-A5LI-01A-11D-A309-01 TCGA-OR-A5LI-01A-11D-A309-01 TCGA-OR-A5LI-01A-11D-A30A-10 TCGA-OR-A5LI-01A-11D-A30A-10 +TCGA-OR-A5LJ-01 TCGA-OR-A5LJ-01 TCGA-OR-A5LJ TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 54 Atypical Mitotic Figures Present TCGA-OR-A5LJ TCGA-OR-A5LJ-01A M1 Lung Involvement Cytoplasm presence <= 25% Present -20069 2633 1105 0 Diffuse Architecture Present Lymph nodes Both Clinical and Biochemical Assessments Androgen|Cortisol 2013-11-7 FEMALE NO Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 110 Invasion of Tumor Capsule Absent NO Left Imaging Suspected 10 YES YES YES Mitotic Rate > 5/50 HPF Present Necrosis Present YES Nuclear Grade III or IV Present true No N1 T2 Stage IV TCGA-OR-A5LJ.B93073AF-A15A-4BAB-AC70-E16D89256DFC.pdf A5LJ WITH TUMOR Persistent distant metastases YES YES Progressive Disease NO R2 Primary Tumor 01 Sinusoid Invasion Present NO YES OR Adrenal A DECEASED 8 Venous Invasion Present 2005 TCGA-OR-A5LJ-01A-11D-A29I-10 744e863c-e24e-4eee-b0ee-ee24f2ef7401 TCGA-OR-A5LJ-01 TCGA-OR-A5LJ-01 E6673A36-9456-4788-8E0A-FED99D1849B9 TCGA-OR-A5LJ-01A-11D-A29J-05 744e863c-e24e-4eee-b0ee-ee24f2ef7401 744e863c-e24e-4eee-b0ee-ee24f2ef7401 TCGA-OR-A5LJ-01A-11D-A29H-01 TCGA-OR-A5LJ-01 TCGA-OR-A5LJ-01 744e863c-e24e-4eee-b0ee-ee24f2ef7401 TCGA-OR-A5LJ-01A-11D-A29H-01 TCGA-OR-A5LJ-01A-11D-A29I-10 TCGA-OR-A5LJ-01A-11D-A29I-10 +TCGA-OR-A5LK-01 TCGA-OR-A5LK-01 TCGA-OR-A5LK TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 62 Atypical Mitotic Figures Absent TCGA-OR-A5LK-F71750 TCGA-OR-A5LK TCGA-OR-A5LK-01A M0 Normal Cytoplasm presence <= 25% Present -22919 2096 0 2740 Diffuse Architecture Present None 2015-3-30 MALE NO Adrenocortical Carcinoma- Oncocytic Type No C74.0 8370/3 C74.0 YES 120 Invasion of Tumor Capsule Absent NO Right NO 7 YES YES Mitotic Rate > 5/50 HPF Present Necrosis Present NO Nuclear Grade III or IV Present true No N0 T2 Stage II TCGA-OR-A5LK.4917D13C-6355-4E4B-8189-FE4443313F53.pdf A5LK TUMOR FREE No imaging evidence of disease YES NO Complete Remission/Response NO R0 Primary Tumor 01 Sinusoid Invasion Absent YES NO NO YES OR Adrenal A LIVING 5 Venous Invasion Absent 2007 TCGA-OR-A5LK-01A-11D-A29I-10 6bce4f20-babf-4cbd-a962-6b977986e19d TCGA-OR-A5LK-01 TCGA-OR-A5LK-01 4706C9EA-9C64-4CFA-A727-C371EE8CAAC8 TCGA-OR-A5LK-01A-11D-A29J-05 6bce4f20-babf-4cbd-a962-6b977986e19d 6bce4f20-babf-4cbd-a962-6b977986e19d TCGA-OR-A5LK-01A-11D-A29H-01 TCGA-OR-A5LK-01 TCGA-OR-A5LK-01 6bce4f20-babf-4cbd-a962-6b977986e19d TCGA-OR-A5LK-01A-11D-A29H-01 TCGA-OR-A5LK-01A-11D-A29I-10 TCGA-OR-A5LK-01A-11D-A29I-10 +TCGA-OR-A5LL-01 TCGA-OR-A5LL-01 TCGA-OR-A5LL TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 75 Atypical Mitotic Figures Present TCGA-OR-A5LL TCGA-OR-A5LL-01A M0 Normal Cytoplasm presence <= 25% Present -27607 1882 1613 0 Diffuse Architecture Present Both Clinical and Biochemical Assessments Androgen|Cortisol 2013-11-27 FEMALE NO Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 180 Invasion of Tumor Capsule Present NO Right 10 15 YES YES NO Mitotic Rate > 5/50 HPF Present Necrosis Present YES Nuclear Grade III or IV Present 0 true No N0 T2 Stage II TCGA-OR-A5LL.A898F0C7-9596-4DF1-9784-CAACFAB672D8.pdf A5LL WITH TUMOR No imaging evidence of disease YES YES Complete Remission/Response NO R0 Primary Tumor 01 Sinusoid Invasion Absent YES YES NO YES OR Adrenal A DECEASED 7 Venous Invasion Absent 2007 TCGA-OR-A5LL-01A-11D-A29I-10 63f6ab7c-2ef7-42a3-afda-0289383a6976 TCGA-OR-A5LL-01 TCGA-OR-A5LL-01 6E7DE852-5C21-4694-9B99-22FE8D927A7F TCGA-OR-A5LL-01A-11D-A29J-05 63f6ab7c-2ef7-42a3-afda-0289383a6976 63f6ab7c-2ef7-42a3-afda-0289383a6976 TCGA-OR-A5LL-01A-11D-A29H-01 TCGA-OR-A5LL-01 TCGA-OR-A5LL-01 63f6ab7c-2ef7-42a3-afda-0289383a6976 TCGA-OR-A5LL-01A-11D-A29H-01 TCGA-OR-A5LL-01A-11D-A29I-10 TCGA-OR-A5LL-01A-11D-A29I-10 +TCGA-OR-A5LM-01 TCGA-OR-A5LM-01 TCGA-OR-A5LM TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 23 Atypical Mitotic Figures Present TCGA-OR-A5LM-F71749 TCGA-OR-A5LM TCGA-OR-A5LM-01A M0 Normal Cytoplasm presence <= 25% Present -8735 1821 0 1858 Diffuse Architecture Present Both Clinical and Biochemical Assessments Estrogen 2015-3-30 MALE NO Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 120 Invasion of Tumor Capsule Present NO Right NO 32 18 YES YES Mitotic Rate > 5/50 HPF Present Necrosis Present NO Nuclear Grade III or IV Present 0 true No N0 T2 Stage II TCGA-OR-A5LM.57A7E2E6-210B-41B1-8C22-9ED4930BCDEA.pdf A5LM TUMOR FREE No imaging evidence of disease YES YES Complete Remission/Response NO R0 Primary Tumor 01 Sinusoid Invasion Absent YES NO NO YES OR Adrenal A LIVING 7 Venous Invasion Absent 2008 TCGA-OR-A5LM-01A-11D-A29I-10 3367029a-3e6f-49ef-8ff5-421aa0c71b4b TCGA-OR-A5LM-01 TCGA-OR-A5LM-01 8B5ED987-A6A4-4BEB-852A-E10F4CF37A30 TCGA-OR-A5LM-01A-11D-A29J-05 3367029a-3e6f-49ef-8ff5-421aa0c71b4b 3367029a-3e6f-49ef-8ff5-421aa0c71b4b TCGA-OR-A5LM-01A-11D-A29H-01 TCGA-OR-A5LM-01 TCGA-OR-A5LM-01 3367029a-3e6f-49ef-8ff5-421aa0c71b4b TCGA-OR-A5LM-01A-11D-A29H-01 +TCGA-OR-A5LN-01 TCGA-OR-A5LN-01 TCGA-OR-A5LN TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 31 Atypical Mitotic Figures Present TCGA-OR-A5LN-F71751 TCGA-OR-A5LN TCGA-OR-A5LN-01A M0 Normal Cytoplasm presence <= 25% Present -11414 1790 0 2342 Diffuse Architecture Present None 2015-3-30 FEMALE NO Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 120 Invasion of Tumor Capsule Present NO Right NO 10 6 NO NO Mitotic Rate > 5/50 HPF Present Necrosis Absent NO Nuclear Grade III or IV Present 0 true No N0 T2 Stage II TCGA-OR-A5LN.92EE5592-2CEC-4F7C-BF7B-A0A2CEE5E169.pdf A5LN TUMOR FREE No imaging evidence of disease NO YES Complete Remission/Response NO R0 Primary Tumor 01 Sinusoid Invasion Absent NO YES OR Adrenal A LIVING 6 Venous Invasion Absent 2008 TCGA-OR-A5LN-01A-11D-A29I-10 8ab4c4ac-e348-4fa7-b15b-1b640d771fae TCGA-OR-A5LN-01 TCGA-OR-A5LN-01 AEE4D7BD-057F-4C4A-9544-2527784CBD29 TCGA-OR-A5LN-01A-11D-A29J-05 8ab4c4ac-e348-4fa7-b15b-1b640d771fae 8ab4c4ac-e348-4fa7-b15b-1b640d771fae TCGA-OR-A5LN-01A-11D-A29H-01 TCGA-OR-A5LN-01 TCGA-OR-A5LN-01 8ab4c4ac-e348-4fa7-b15b-1b640d771fae TCGA-OR-A5LN-01A-11D-A29H-01 TCGA-OR-A5LN-01A-11D-A29I-10 TCGA-OR-A5LN-01A-11D-A29I-10 +TCGA-OR-A5LO-01 TCGA-OR-A5LO-01 TCGA-OR-A5LO TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland YES YES 61 Atypical Mitotic Figures Present TCGA-OR-A5LO-F71748 TCGA-OR-A5LO TCGA-OR-A5LO-01A M0 Normal Cytoplasm presence <= 25% Present -22370 1700 2405 0 1949 1309 153 Diffuse Architecture Present Both Clinical and Biochemical Assessments Androgen|Estrogen 2015-3-30 FEMALE NO YES Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 170 Invasion of Tumor Capsule Present NO Right NO 19 12 YES YES Mitotic Rate > 5/50 HPF Present Necrosis Present Imaging Lung Distant Metastasis YES YES Nuclear Grade III or IV Present 0 true No N0 T2 Stage II TCGA-OR-A5LO.45C2478C-53EF-4422-A9EF-33C40A3AA275.pdf A5LO WITH TUMOR No imaging evidence of disease YES YES Complete Remission/Response NO R0 Primary Tumor 01 Sinusoid Invasion Absent YES YES NO YES OR Adrenal A DECEASED 7 Venous Invasion Absent 2008 TCGA-OR-A5LO-01A-11D-A29I-10 a70e4d3e-993e-4ab7-95b9-1c52f452ef63 TCGA-OR-A5LO-01 TCGA-OR-A5LO-01 51B5F64E-06A8-48C6-AD83-B7006B707D55 TCGA-OR-A5LO-01A-11D-A29J-05 a70e4d3e-993e-4ab7-95b9-1c52f452ef63 a70e4d3e-993e-4ab7-95b9-1c52f452ef63 TCGA-OR-A5LO-01A-11D-A29H-01 TCGA-OR-A5LO-01 TCGA-OR-A5LO-01 a70e4d3e-993e-4ab7-95b9-1c52f452ef63 TCGA-OR-A5LO-01A-11D-A29H-01 TCGA-OR-A5LO-01A-11D-A29I-10 TCGA-OR-A5LO-01A-11D-A29I-10 +TCGA-OR-A5LP-01 TCGA-OR-A5LP-01 TCGA-OR-A5LP TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 37 Atypical Mitotic Figures Absent TCGA-OR-A5LP-F59578 TCGA-OR-A5LP TCGA-OR-A5LP-01A M0 Normal Cytoplasm presence <= 25% Present -13574 1396 0 1857 Diffuse Architecture Present None 2014-5-15 FEMALE NO Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 120 Invasion of Tumor Capsule Present NO Right NO 21 0 NO NO Mitotic Rate > 5/50 HPF Absent Necrosis Absent NO Nuclear Grade III or IV Present 0 true No N0 T2 Stage II TCGA-OR-A5LP.FCD998EA-2EEA-4A94-80A6-D87F962BBC87.pdf A5LP TUMOR FREE No imaging evidence of disease NO YES Complete Remission/Response NO R0 Primary Tumor 01 Sinusoid Invasion Present NO YES OR Adrenal A LIVING 5 Venous Invasion Absent 2009 TCGA-OR-A5LP-01A-11D-A29I-10 62428588-d744-40ee-9318-f09c64e95898 TCGA-OR-A5LP-01 TCGA-OR-A5LP-01 7D9FD532-600B-4BF1-987D-ADAA2895F9AB TCGA-OR-A5LP-01A-11D-A29J-05 62428588-d744-40ee-9318-f09c64e95898 62428588-d744-40ee-9318-f09c64e95898 TCGA-OR-A5LP-01A-11D-A29H-01 TCGA-OR-A5LP-01 TCGA-OR-A5LP-01 62428588-d744-40ee-9318-f09c64e95898 TCGA-OR-A5LP-01A-11D-A29H-01 TCGA-OR-A5LP-01A-11D-A29I-10 TCGA-OR-A5LP-01A-11D-A29I-10 +TCGA-OR-A5LR-01 TCGA-OR-A5LR-01 TCGA-OR-A5LR TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 30 Atypical Mitotic Figures Present TCGA-OR-A5LR-F59581 TCGA-OR-A5LR TCGA-OR-A5LR-01A M0 Normal Cytoplasm presence <= 25% Present -11261 482 0 853 Diffuse Architecture Present Both Clinical and Biochemical Assessments Mineralocorticoids 2014-5-15 FEMALE NO Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 50 Invasion of Tumor Capsule Present NO Left NO 6 YES YES Mitotic Rate > 5/50 HPF Present Necrosis Present NO Nuclear Grade III or IV Present true No N0 T2 Stage II TCGA-OR-A5LR.A1C555F3-4513-45C6-9A39-968902130B94.pdf A5LR TUMOR FREE No imaging evidence of disease YES NO Complete Remission/Response NO R0 Primary Tumor 01 Sinusoid Invasion Absent NO NO YES OR Adrenal A LIVING 7 Venous Invasion Absent 2011 TCGA-OR-A5LR-01A-11D-A29I-10 70b87c96-d585-4260-aa9a-7a5ee37d1b10 TCGA-OR-A5LR-01 TCGA-OR-A5LR-01 TCGA-OR-A5LR-01A-11D-A29J-05 70b87c96-d585-4260-aa9a-7a5ee37d1b10 70b87c96-d585-4260-aa9a-7a5ee37d1b10 TCGA-OR-A5LR-01A-11D-A29H-01 TCGA-OR-A5LR-01 TCGA-OR-A5LR-01 70b87c96-d585-4260-aa9a-7a5ee37d1b10 TCGA-OR-A5LR-01A-11D-A29H-01 TCGA-OR-A5LR-01A-11D-A29I-10 TCGA-OR-A5LR-01A-11D-A29I-10 +TCGA-OR-A5LS-01 TCGA-OR-A5LS-01 TCGA-OR-A5LS TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 34 Atypical Mitotic Figures Absent TCGA-OR-A5LS-F59579 TCGA-OR-A5LS TCGA-OR-A5LS-01A M0 Normal Cytoplasm presence <= 25% Present -12663 725 0 1096 Diffuse Architecture Absent Both Clinical and Biochemical Assessments Androgen|Cortisol 2014-5-15 FEMALE NO Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 100 Invasion of Tumor Capsule Absent NO Right NO 7 YES YES Mitotic Rate > 5/50 HPF Present Necrosis Present NO Nuclear Grade III or IV Present true No N0 T2 Stage II TCGA-OR-A5LS.31004530-E017-4913-A8AA-7AE709EAE0F1.pdf A5LS TUMOR FREE No imaging evidence of disease YES NO Complete Remission/Response NO R0 Primary Tumor 01 Sinusoid Invasion Present YES NO NO YES OR Adrenal A LIVING 6 Venous Invasion Present 2011 TCGA-OR-A5LS-01A-11D-A29I-10 67a0828e-86c3-4c46-b05c-104000425669 TCGA-OR-A5LS-01 TCGA-OR-A5LS-01 9F4DFEE6-3193-44C2-98BE-6649DB11A67C TCGA-OR-A5LS-01A-11D-A29J-05 67a0828e-86c3-4c46-b05c-104000425669 67a0828e-86c3-4c46-b05c-104000425669 TCGA-OR-A5LS-01A-11D-A29H-01 TCGA-OR-A5LS-01 TCGA-OR-A5LS-01 67a0828e-86c3-4c46-b05c-104000425669 TCGA-OR-A5LS-01A-11D-A29H-01 TCGA-OR-A5LS-01A-11D-A29I-10 TCGA-OR-A5LS-01A-11D-A29I-10 +TCGA-OR-A5LT-01 TCGA-OR-A5LT-01 TCGA-OR-A5LT TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 57 Atypical Mitotic Figures Present TCGA-OR-A5LT-F59582 TCGA-OR-A5LT TCGA-OR-A5LT-01A M0 Normal Cytoplasm presence <= 25% Present -21032 178 0 549 Diffuse Architecture Present None 2014-5-15 MALE NO Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 160 Invasion of Tumor Capsule Present NO Left NO 18 10 YES YES Mitotic Rate > 5/50 HPF Present Necrosis Present NO Nuclear Grade III or IV Present 0 true No N0 T3 Stage III TCGA-OR-A5LT.6C9B7DE2-682F-4F4A-8879-159F9989C40C.pdf A5LT TUMOR FREE No imaging evidence of disease YES YES Complete Remission/Response NO R0 Primary Tumor 01 Sinusoid Invasion Absent YES NO NO YES OR Adrenal A LIVING 8 Venous Invasion Present 2012 TCGA-OR-A5LT-01A-11D-A29I-10 c18bba08-b10a-4237-96a6-5f89efa59826 TCGA-OR-A5LT-01 TCGA-OR-A5LT-01 88870133-85F4-49A2-92D1-12E92055C7E7 TCGA-OR-A5LT-01A-11D-A29J-05 c18bba08-b10a-4237-96a6-5f89efa59826 c18bba08-b10a-4237-96a6-5f89efa59826 TCGA-OR-A5LT-01A-11D-A29H-01 TCGA-OR-A5LT-01 TCGA-OR-A5LT-01 c18bba08-b10a-4237-96a6-5f89efa59826 TCGA-OR-A5LT-01A-11D-A29H-01 TCGA-OR-A5LT-01A-11D-A29I-10 TCGA-OR-A5LT-01A-11D-A29I-10 +TCGA-OU-A5PI-01 TCGA-OU-A5PI-01 TCGA-OU-A5PI TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland YES YES 53 Atypical Mitotic Figures Absent TCGA-OU-A5PI-F65711 TCGA-OU-A5PI TCGA-OU-A5PI-01A M1 Lung Involvement Cytoplasm presence <= 25% Absent -19492 577 0 1171 384 351 Diffuse Architecture Absent None 2014-9-29 FEMALE YES NO Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 160 Invasion of Tumor Capsule Present NO Left NO 3 Other, specify Resection YES YES NO Mitotic Rate > 5/50 HPF Absent Necrosis Present Imaging Lung Distant Metastasis YES YES Nuclear Grade III or IV Absent 3 false No N1 T2 Stage IV TCGA-OU-A5PI.2AA8FA9B-A202-48AB-A543-6E0B1B45B1D4.pdf A5PI WITH TUMOR Persistent distant metastases YES YES Stable Disease NO RET Negative Primary Tumor 01 Sinusoid Invasion Absent NO YES OU Adrenal A LIVING 2 Venous Invasion Absent 2011 TCGA-OU-A5PI-01A-12D-A29I-10 7d3369ab-b556-45c5-aaaf-e7cd9ac0d454 TCGA-OU-A5PI-01 TCGA-OU-A5PI-01 A6D0B6AB-D7DE-4233-805C-E85505D0BE77 TCGA-OU-A5PI-01A-12D-A29J-05 7d3369ab-b556-45c5-aaaf-e7cd9ac0d454 7d3369ab-b556-45c5-aaaf-e7cd9ac0d454 TCGA-OU-A5PI-01A-12D-A29H-01 TCGA-OU-A5PI-01 TCGA-OU-A5PI-01 7d3369ab-b556-45c5-aaaf-e7cd9ac0d454 TCGA-OU-A5PI-01A-12D-A29H-01 TCGA-OU-A5PI-01A-12D-A29I-10 TCGA-OU-A5PI-01A-12D-A29I-10 +TCGA-P6-A5OF-01 TCGA-P6-A5OF-01 TCGA-P6-A5OF TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 55 TCGA-P6-A5OF M0 Vena Cava Involvement/thrombus -20106 207 0 Both Clinical and Biochemical Assessments Androgen|Cortisol 2013-8-15 FEMALE NO Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES Right NO Mitotic Rate > 5/50 HPF Present Necrosis Present YES Nuclear Grade III or IV Present No N0 T4 Stage III A5OF WITH TUMOR Persistent distant metastases NO NO NO RX Primary Tumor 01 NO YES P6 Adrenal DECEASED 4 Venous Invasion Present 2010 TCGA-P6-A5OF-01A-11D-A29I-10 ca5f547a-8ec9-4436-9878-1f1cab2fa329 TCGA-P6-A5OF-01 TCGA-P6-A5OF-01 TCGA-P6-A5OF-01A-11D-A29J-05 ca5f547a-8ec9-4436-9878-1f1cab2fa329 ca5f547a-8ec9-4436-9878-1f1cab2fa329 TCGA-P6-A5OF-01 ca5f547a-8ec9-4436-9878-1f1cab2fa329 TCGA-P6-A5OF-01A-11D-A29I-10 TCGA-P6-A5OF-01A-11D-A29I-10 +TCGA-P6-A5OG-01 TCGA-P6-A5OG-01 TCGA-P6-A5OG TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 45 Atypical Mitotic Figures Absent TCGA-P6-A5OG TCGA-P6-A5OG-01A M1 Lung Involvement Cytoplasm presence <= 25% Present -16659 426 383 0 Diffuse Architecture Absent Biochemical Assessment Cortisol 2013-8-15 FEMALE NO Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 200 Invasion of Tumor Capsule Present NO Left 6 Biopsy Proven NO Mitotic Rate > 5/50 HPF Absent Necrosis Present YES Nuclear Grade III or IV Present 0 false Yes N0 T4 Stage IV TCGA-P6-A5OG.4F591001-D8B2-4B68-A219-45EBA6903A80.pdf A5OG WITH TUMOR Persistent distant metastases NO YES Complete Remission/Response NO R2 Primary Tumor 01 Sinusoid Invasion Absent NO YES P6 Adrenal A DECEASED 4 Venous Invasion Absent 2011 TCGA-P6-A5OG-01A-22D-A29I-10 b5a3bdce-d4ad-43a6-8fbc-1e9d31dc2564 18B5333E-0649-4BBB-9271-5779C2D13BC8 TCGA-P6-A5OG-01A-22D-A29J-05 b5a3bdce-d4ad-43a6-8fbc-1e9d31dc2564 b5a3bdce-d4ad-43a6-8fbc-1e9d31dc2564 TCGA-P6-A5OG-01A-22D-A29H-01 TCGA-P6-A5OG-01 TCGA-P6-A5OG-01 b5a3bdce-d4ad-43a6-8fbc-1e9d31dc2564 TCGA-P6-A5OG-01A-22D-A29H-01 TCGA-P6-A5OG-01A-22D-A29I-10 TCGA-P6-A5OG-01A-22D-A29I-10 +TCGA-P6-A5OH-01 TCGA-P6-A5OH-01 TCGA-P6-A5OH TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 59 TCGA-P6-A5OH TCGA-P6-A5OH-01A M1 Cytoplasm presence <= 25% Present -21627 1021 0 0 Diffuse Architecture Present 2014-3-25 FEMALE NO Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 200 NO Right Biopsy Proven NO Necrosis Present NO Nuclear Grade III or IV Present false No N0 T4 Stage IV TCGA-P6-A5OH.349F5609-E653-4CF0-B63C-AF01D68D40E7.pdf A5OH WITH TUMOR NO NO R2 Primary Tumor 01 NO YES P6 Adrenal A DECEASED 4 2010 TCGA-P6-A5OH-01A-11D-A30A-10 TCGA-P6-A5OH-01A-11D-A309-01 TCGA-P6-A5OH-01A-11D-A309-01 TCGA-P6-A5OH-01A-11D-A30A-10 TCGA-P6-A5OH-01A-11D-A30A-10 +TCGA-PA-A5YG-01 TCGA-PA-A5YG-01 TCGA-PA-A5YG TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 51 TCGA-PA-A5YG-F69304 TCGA-PA-A5YG TCGA-PA-A5YG-01A M0 Normal -18926 85 0 756 2014-12-31 MALE NO Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 440 NO Left NO NO NO NO true No N0 T2 Stage II TCGA-PA-A5YG.9C523464-BFDB-4C7A-972E-2EBECDBBFF3E.pdf A5YG TUMOR FREE No imaging evidence of disease NO NO Complete Remission/Response NO R0 Primary Tumor 01 YES NO PA Adrenal A LIVING 2012 TCGA-PA-A5YG-01A-11D-A29I-10 379e288c-fa30-460c-bb57-d3b6f09b1483 TCGA-PA-A5YG-01 TCGA-PA-A5YG-01 78AB014F-E03C-4109-9348-34862B626270 TCGA-PA-A5YG-01A-11D-A29J-05 379e288c-fa30-460c-bb57-d3b6f09b1483 379e288c-fa30-460c-bb57-d3b6f09b1483 TCGA-PA-A5YG-01A-11D-A29H-01 TCGA-PA-A5YG-01 TCGA-PA-A5YG-01 379e288c-fa30-460c-bb57-d3b6f09b1483 TCGA-PA-A5YG-01A-11D-A29H-01 TCGA-PA-A5YG-01A-11D-A29I-10 TCGA-PA-A5YG-01A-11D-A29I-10 +TCGA-PK-A5H8-01 TCGA-PK-A5H8-01 TCGA-PK-A5H8 TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 42 Atypical Mitotic Figures Present TCGA-PK-A5H8-F65384 TCGA-PK-A5H8 TCGA-PK-A5H8-01A M0 Cytoplasm presence <= 25% Present -15373 3025 0 3623 Diffuse Architecture Present 2014-9-22 MALE Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 210 Invasion of Tumor Capsule Absent NO Right NO 9 NO Mitotic Rate > 5/50 HPF Present Necrosis Present NO Nuclear Grade III or IV Present false No N0 T2 Stage II TCGA-PK-A5H8.706EC715-C6CD-49A9-8993-D6E5B20AED95.pdf A5H8 TUMOR FREE No imaging evidence of disease NO NO Complete Remission/Response NO R0 Primary Tumor 01 Sinusoid Invasion Absent NO YES PK Adrenal A LIVING 7 Venous Invasion Present 2004 TCGA-PK-A5H8-01A-11D-A29I-10 cdb932bf-d02c-4c3c-9e71-22eb12623977 TCGA-PK-A5H8-01 TCGA-PK-A5H8-01 E8C935A8-A842-414D-9E8A-AF40D7BE64A9 TCGA-PK-A5H8-01A-11D-A29J-05 cdb932bf-d02c-4c3c-9e71-22eb12623977 cdb932bf-d02c-4c3c-9e71-22eb12623977 TCGA-PK-A5H8-01 cdb932bf-d02c-4c3c-9e71-22eb12623977 TCGA-PK-A5H8-01A-11D-A29I-10 TCGA-PK-A5H8-01A-11D-A29I-10 +TCGA-PK-A5H9-01 TCGA-PK-A5H9-01 TCGA-PK-A5H9 TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 27 Atypical Mitotic Figures Present TCGA-PK-A5H9-F62621 TCGA-PK-A5H9 TCGA-PK-A5H9-01A M0 Cytoplasm presence <= 25% Present -10173 92 0 616 Diffuse Architecture Present Both Clinical and Biochemical Assessments Androgen 2014-8-11 FEMALE YES Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 90 Invasion of Tumor Capsule Absent NO Right NO 2 NO NO Mitotic Rate > 5/50 HPF Absent Necrosis Absent NO Nuclear Grade III or IV Absent false No N0 T2 Stage II TCGA-PK-A5H9.A323FD5A-1C3E-49D3-A7EA-04E3663D6883.pdf A5H9 TUMOR FREE No imaging evidence of disease NO NO Complete Remission/Response NO R0 Primary Tumor 01 Sinusoid Invasion Absent NO YES PK Adrenal A LIVING 4 Venous Invasion Present 2012 TCGA-PK-A5H9-01A-11D-A29I-10 207683b6-6a60-44ef-8eb2-d26ed9a7de76 TCGA-PK-A5H9-01 TCGA-PK-A5H9-01 52E291F2-445C-4088-88AD-04034A488599 TCGA-PK-A5H9-01A-11D-A29J-05 207683b6-6a60-44ef-8eb2-d26ed9a7de76 207683b6-6a60-44ef-8eb2-d26ed9a7de76 TCGA-PK-A5H9-01A-11D-A29H-01 TCGA-PK-A5H9-01 TCGA-PK-A5H9-01 207683b6-6a60-44ef-8eb2-d26ed9a7de76 TCGA-PK-A5H9-01A-11D-A29H-01 TCGA-PK-A5H9-01A-11D-A29I-10 TCGA-PK-A5H9-01A-11D-A29I-10 +TCGA-PK-A5HA-01 TCGA-PK-A5HA-01 TCGA-PK-A5HA TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 63 Atypical Mitotic Figures Present TCGA-PK-A5HA-F62620 TCGA-PK-A5HA TCGA-PK-A5HA-01A M0 Cytoplasm presence <= 25% Present -23345 701 0 1201 Diffuse Architecture Present None 2014-8-11 MALE Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 130 Invasion of Tumor Capsule Present NO Left NO 1 NO NO Mitotic Rate > 5/50 HPF Present Necrosis Present NO Nuclear Grade III or IV Present 0 false No N0 T1 Stage I TCGA-PK-A5HA.B98EC873-CB6D-4395-A473-C46EC4D2DB00.pdf A5HA TUMOR FREE No imaging evidence of disease NO YES Complete Remission/Response NO R0 Primary Tumor 01 Sinusoid Invasion Present NO YES PK Adrenal A LIVING 8 Venous Invasion Absent 2011 TCGA-PK-A5HA-01A-11D-A29I-10 69d7a879-cf23-44d0-8a44-050b7a3f4b03 TCGA-PK-A5HA-01 TCGA-PK-A5HA-01 85DDE23B-20FB-450B-9D82-609D7F4C6207 TCGA-PK-A5HA-01A-11D-A29J-05 69d7a879-cf23-44d0-8a44-050b7a3f4b03 69d7a879-cf23-44d0-8a44-050b7a3f4b03 TCGA-PK-A5HA-01A-11D-A29H-01 TCGA-PK-A5HA-01 TCGA-PK-A5HA-01 69d7a879-cf23-44d0-8a44-050b7a3f4b03 TCGA-PK-A5HA-01A-11D-A29H-01 TCGA-PK-A5HA-01A-11D-A29I-10 TCGA-PK-A5HA-01A-11D-A29I-10 +TCGA-PK-A5HB-01 TCGA-PK-A5HB-01 TCGA-PK-A5HB TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 63 TCGA-PK-A5HB -23293 0 1293 2013-9-16 MALE Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES Left 2 NO YES Yes A5HB WITH TUMOR YES YES YES Primary Tumor 01 NO YES PK Adrenal LIVING 2003 TCGA-PK-A5HB-01A-11D-A29I-10 c92f7cf7-f63b-4f04-a391-193f65a6f8a7 TCGA-PK-A5HB-01 TCGA-PK-A5HB-01 TCGA-PK-A5HB-01A-11D-A29J-05 c92f7cf7-f63b-4f04-a391-193f65a6f8a7 c92f7cf7-f63b-4f04-a391-193f65a6f8a7 TCGA-PK-A5HB-01A-11D-A29H-01 TCGA-PK-A5HB-01 TCGA-PK-A5HB-01 c92f7cf7-f63b-4f04-a391-193f65a6f8a7 TCGA-PK-A5HB-01A-11D-A29H-01 TCGA-PK-A5HB-01A-11D-A29I-10 TCGA-PK-A5HB-01A-11D-A29I-10 +TCGA-PK-A5HC-01 TCGA-PK-A5HC-01 TCGA-PK-A5HC TCGA Adrenocortical Cancer (ACC) adrenocortical cancer Adrenal gland 44 TCGA-PK-A5HC TCGA-PK-A5HC-01A M0 Vena Cava Involvement/thrombus Cytoplasm presence <= 25% Present -16182 359 0 679 Diffuse Architecture Present Both Clinical and Biochemical Assessments Androgen|Cortisol 2014-3-13 FEMALE Adrenocortical carcinoma- Usual Type No C74.0 8370/3 C74.0 YES 120 Invasion of Tumor Capsule Present NO Right 3 19 YES NO Mitotic Rate > 5/50 HPF Present Necrosis Present YES Nuclear Grade III or IV Present 0 false No N0 T4 Stage III TCGA-PK-A5HC.760C639D-B101-441C-8081-30908D56EDA2.pdf A5HC WITH TUMOR No imaging evidence of disease NO YES Complete Remission/Response NO R1 Primary Tumor 01 Sinusoid Invasion Present YES YES NO YES PK Adrenal A LIVING 9 Venous Invasion Present 2011 TCGA-PK-A5HC-01A-11D-A30A-10 TCGA-PK-A5HC-01A-11D-A309-01 TCGA-PK-A5HC-01A-11D-A309-01 TCGA-PK-A5HC-01A-11D-A30A-10 TCGA-PK-A5HC-01A-11D-A30A-10